薦念誤
Catalog #
匂舌舘是
掻勲
Cas No.
Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001-2500 5 x 500 レmol 37839-81-9
Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form A 001-2500 H 5 x 500 mg 60-92-4
Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001-2500 S 5 x 500 レmol 37839-81-9
Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001-500 500 レmol ~176 mg 37839-81-9
Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form A 001-500 H 500 mg ~1.5 mmol 60-92-4
Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001-500 S 500 レmol 37839-81-9
Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade A 002-05 S 5 レmol ~1.8 mg 73208-40-9
Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade A 002-05 T 5 レmol ~2.2 mg 151837-09-1
Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade A 002-25 S 5 x 5 レmol 73208-40-9
Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade A 002-25 T 5 x 5 レmol 151837-09-1
Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade A 003-10 S 10 レmol ~3.7 mg 71774-13-5
Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), economy grade A 003-10 T 10 レmol ~4.5 mg 93602-66-5
Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade A 003-50 S 5 x 10 レmol 71774-13-5
Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), economy grade A 003-50 T 5 x 10 レmol 93602-66-5
Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) A 005-250 5 x 50 レmol 19341-57-2
Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) A 005-50 50 レmol ~18 mg 19341-57-2
Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) A 006-05 5 レmol ~1.9 mg 118275-99-3
Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) A 006-25 5 x 5 レmol 118275-99-3
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AEA-cAMPS-Agarose ) A 007-06 0.6 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AEA-cAMPS-Agarose ) A 007-25 2.5 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AEA-cAMPS-Agarose ) A 007-60 6 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AEA-cAMPS-Agarose ) A 008-06 0.6 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AEA-cAMPS-Agarose ) A 008-25 2.5 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AEA-cAMPS-Agarose ) A 008-60 6 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AET-cGMPS-Agarose ) A 009-06 0.6 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AET-cGMPS-Agarose ) A 009-25 2.5 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AET-cGMPS-Agarose ) A 009-60 6 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AET-cGMPS-Agarose ) A 010-06 0.6 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AET-cGMPS-Agarose ) A 010-25 2.5 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AET-cGMPS-Agarose ) A 010-60 6 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) A 011-10 10 レmol ~4.4 mg 39824-30-1
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) A 011-50 5 x 10 レmol 39824-30-1
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AHA-cAMPS-Agarose ) A 012-06 0.6 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AHA-cAMPS-Agarose ) A 012-25 2.5 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AHA-cAMPS-Agarose ) A 012-60 6 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013-06 0.6 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013-25 2.5 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013-60 6 ml none
8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) A 014-10 10 レmol ~3.9 mg 31966-52-6
8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) A 014-50 5 x 10 レmol 31966-52-6
2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ュ-cAMP ) A 015-05 5 レmol ~1.9 mg 50663-90-6
2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ュ-cAMP ) A 015-25 5 x 5 レmol 50663-90-6
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) A 016-05 5 レmol ~1.9 mg 61363-29-9
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) A 016-25 5 x 5 レmol 61363-29-9
8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) A 017-05 5 レmol ~2.1 mg 82927-68-2
8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) A 017-25 5 x 5 レmol 82927-68-2
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cGMP-Agarose ) A 019-06 0.6 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cGMP-Agarose ) A 019-25 2.5 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cGMP-Agarose ) A 019-60 6 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AEA-cAMP-Agarose ) A 020-06 0.6 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AEA-cAMP-Agarose ) A 020-25 2.5 ml none
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AEA-cAMP-Agarose ) A 020-60 6 ml none
5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) A 021-10 10 レmol ~2.7 mg 14365-44-7
5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) A 021-50 5 x 10 レmol 14365-44-7
Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) A 022-01 1 レmol ~0.4 mg 159764-93-9
Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) A 022-05 5 x 1 レmol 159764-93-9
Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate ( 1-NO-cAMP ) A 023-05 5 レmol ~1.8 mg 75912-25-3
Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate ( 1-NO-cAMP ) A 023-25 5 x 5 レmol 75912-25-3
Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) A 024-05 5 レmol ~1.9 mg 118276-00-9
Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) A 024-25 5 x 5 レmol 118276-00-9
N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) A 026-05 5 レmol ~2.5 mg 767272-34-4
N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) A 026-25 5 x 5 レmol 767272-34-4
2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) A 027-05 5 レmol ~1.8 mg 42467-66-3
2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) A 027-25 5 x 5 レmol 42467-66-3
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP-Agarose ) A 028-06 0.6 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP-Agarose ) A 028-25 2.5 ml none
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP-Agarose ) A 028-60 6 ml none
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) A 029-05 5 レmol ~2.1 mg 115974-70-4
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) A 029-25 5 x 5 レmol 115974-70-4
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) A 031-05 5 レmol ~2.1 mg 66311-09-9
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) A 031-25 5 x 5 レmol 66311-09-9
8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) A 032-05 5 レmol ~2.4 mg 144509-87-5
8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) A 032-25 5 x 5 レmol 144509-87-5
8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) A 033-05 5 レmol ~2.4 mg 214272-05-6
8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) A 033-25 5 x 5 レmol 214272-05-6
Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) A 035-01 1 レmol ~0.4 mg 152218-24-1
Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) A 035-05 5 x 1 レmol 152218-24-1
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP-Agarose ) A 036-06 0.6 ml none
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP-Agarose ) A 036-25 2.5 ml none
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP-Agarose ) A 036-60 6 ml none
Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-メ-S ) A 037-05 5 レmol ~2.2 mg 59331-71-4
Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-メ-S ) A 037-25 5 x 5 レmol 59331-71-4
Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-メ-S ) A 038-05 5 レmol ~2.2 mg 59286-20-3
Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-メ-S ) A 038-25 5 x 5 レmol 59286-20-3
Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-メ-S ) A 039-05 5 レmol ~2.6 mg 58976-49-1
Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-メ-S ) A 039-25 5 x 5 レmol 58976-49-1
Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-メ-S ) A 040-05 5 レmol ~2.6 mg 58976-48-0
Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-メ-S ) A 040-25 5 x 5 レmol 58976-48-0
N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) A 041-05 5 レmol ~1.9 mg 78033-42-8
N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) A 041-25 5 x 5 レmol 78033-42-8
8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) A 043-05 5 レmol ~2.7 mg 53696-59-6
8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) A 043-25 5 x 5 レmol 53696-59-6
8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) A 044-05 5 レmol ~2.3 mg 59432-65-4
8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) A 044-25 5 x 5 レmol 59432-65-4
8- Azidoadenosine ( 8-N3-Ado ) A 045-100 100 レmol ~31 mg 4372-67-2
8- Azidoadenosine ( 8-N3-Ado ) A 045-500 5 x 100 レmol 4372-67-2
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) A 046-05 5 レmol ~2.4 mg pending
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) A 046-25 5 x 5 レmol pending
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) A 048-05 5 レmol ~2.4 mg pending
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) A 048-25 5 x 5 レmol pending
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosporothioate, Rp-isomer; immobilized on agarose gel ( Rp-2'-AHC-cAMPS-Agarose ) A 049-06 0.6 ml
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosporothioate, Rp-isomer; immobilized on agarose gel ( Rp-2'-AHC-cAMPS-Agarose ) A 049-25 2.5 ml
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosporothioate, Rp-isomer; immobilized on agarose gel ( Rp-2'-AHC-cAMPS-Agarose ) A 049-60 6 ml
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050-06 0.6 ml none
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050-25 2.5 ml none
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050-60 6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051-06 0.6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051-25 2.5 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051-60 6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052-06 0.6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052-25 2.5 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052-60 6 ml none
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) A 053-05 5 レmol ~2.2 mg 214276-80-9
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) A 053-25 5 x 5 レmol 214276-80-9
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AHA-cAMP-Agarose ) A 054-06 0.6 ml none
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AHA-cAMP-Agarose ) A 054-25 2.5 ml none
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AHA-cAMP-Agarose ) A 054-60 6 ml none
N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) A 055-05 5 レmol ~2.2 mg 205368-58-7
N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) A 055-25 5 x 5 レmol 205368-58-7
N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AH-cGMP Agarose ) A 056-06 0.6 ml none
N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AH-cGMP Agarose ) A 056-25 2.5 ml none
N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AH-cGMP Agarose ) A 056-60 6 ml none
8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057-06 0.6 ml none
8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057-25 2.5 ml none
8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057-60 6 ml none
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cAMP-Agarose ) A 058-06 0.6 ml none
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cAMP-Agarose ) A 058-25 2.5 ml none
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cAMP-Agarose ) A 058-60 6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cGMP-Agarose ) A 059-06 0.6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cGMP-Agarose ) A 059-25 2.5 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cGMP-Agarose ) A 059-60 6 ml none
Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-ャ-S / ATP-gamma-S ) A 060-05 5 レmol ~2.6 mg 88453-52-5
Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-ャ-S / ATP-gamma-S ) A 060-25 5 x 5 レmol 88453-52-5
Adenosine- 5'- O- phosphosulfate ( APS ) A 061-10 10 レmol ~4.3 mg 102029-95-8
Adenosine- 5'- O- phosphosulfate ( APS ) A 061-50 5 x 10 レmol 102029-95-8
3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) A 063-10 10 レmol ~2.7 mg 2504-55-4
3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) A 063-50 5 x 10 レmol 2504-55-4
3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) A 064-10 10 レmol ~2.8 mg 80015-76-5
3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) A 064-50 5 x 10 レmol 80015-76-5
Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) A 065-01 1 レmol ~0.4 mg 62742-71-6
Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) A 065-05 5 x 1 レmol 62742-71-6
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) A 066-05 5 レmol ~2.4 mg pending
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) A 066-25 5 x 5 レmol pending
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) A 067-05 5 レmol ~2.5 mg pending
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) A 067-25 5 x 5 レmol pending
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) A 068-05 5 レmol ~2.3 mg 214276-94-5
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) A 068-25 5 x 5 レmol 214276-94-5
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069-06 0.6 ml none
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069-25 2.5 ml none
2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069-60 6.0 ml none
Adenosine- 5'- O- (メ, モ- methylene)diphosphate ( AMP-CP ) A 070-05 5 レmol ~2.1 mg 104835-70-3
Adenosine- 5'- O- (メ, モ- methylene)diphosphate ( AMP-CP ) A 070-25 5 x 5 レmol 104835-70-3
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) A 071-05 5 レmol ~2.3 mg 214272-03-4
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) A 071-25 5 x 5 レmol 214272-03-4
2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) A 072-05 5 レmol ~3 mg 173074-70-9
2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) A 072-25 5 x 5 レmol 173074-70-9
N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) A 074-05 5 レmol ~2.9 mg 280577-98-2
N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) A 074-25 5 x 5 レmol 280577-98-2
2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) A 075-05 5 レmol ~2.2 mg pending
2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) A 075-25 5 x 5 レmol pending
Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) A 076-05 5 レmol ~1.8 mg 32465-18-2
Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) A 076-25 5 x 5 レmol 32465-18-2
8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ュ-cAMP ) A 077-01 1 レmol ~0.4 mg 60902-12-7
8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ュ-cAMP ) A 077-05 5 x 1 レmol 60902-12-7
5'- Amino- 5'- deoxyguanosine ( 5'-NH2-Guo ) A 078 Inquire 4099-84-7
5'- Azido- 5'- deoxyguanosine ( 5'-N3-Guo ) A 079 inquire 42204-44-4
2- Amino- 6- chloropurine riboside ( 2-NH2-6-Cl-PuR ) A 080 inquire [2004-07-1]???
2', 3'- O- para- Anisylideneguanosine ( 2',3'-O-pAnisyl-Guo ) A 081 inquire 98346-15-7
Adenylyl- (3' --> 5')- adenosine ( ApA ) A 083-05 5 レmol ~3 mg 2391-46-0
2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) A 084-05 5 レmol ~1.9 mg 16321-98-5
2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) A 084-25 5 x 5 レmol 16321-98-5
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) A 085-05 5 レmol ~2.3 mg 214272-02-3
8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) A 085-25 5 x 5 レmol 214272-02-3
2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ュ-Ado ) A 086-10 10 レmol ~2.9 mg 50663-82-6
2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ュ-Ado ) A 086-50 5 x 10 レmol 50663-82-6
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087-06 0.6 ml none
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087-25 2.5 ml none
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087-60 6 ml none
2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) A 088-05 5 レmol ~1.8 mg 85819-83-6
2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) A 088-25 5 x 5 レmol 85819-83-6
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) A 089-05 5 レmol ~2.2 mg pending
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) A 089-25 5 x 5 レmol pending
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) A 092-05 5 レmol ~1.9 mg pending
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) A 092-25 5 x 5 レmol pending
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) A 093-05 5 レmol ~2 mg pending
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) A 093-25 5 x 5 レmol pending
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) A 094-05 5 レmol ~2 mg 221904-84-3
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) A 094-25 5 x 5 レmol 221904-84-3
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) A 095-05 5 レmol ~2.2 mg pending
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) A 095-25 5 x 5 レmol pending
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) A 096-05 5 レmol ~1.9 mg 66311-08-8
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) A 096-25 5 x 5 レmol 66311-08-8
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) A 097-05 5 レmol ~1.9 mg 66311-12-4
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) A 097-25 5 x 5 レmol 66311-12-4
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) A 098-05 5 レmol ~2.1 mg 403497-54-1
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) A 098-25 5 x 5 レmol 403497-54-1
8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) A 099-05 5 レmol 2.3 mg pending
8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) A 099-25 5 x 5 レmol pending
8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) A 100-001 0.1 レmol ~0.1 mg pending
8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) A 100-005 5 x 0.1 レmol pending
N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) A 101-01 1 レmol ~0.4 mg pending
N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) A 101-05 5 x 1 レmol pending
モ- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) A 102-01 1 レmol ~0.6 mg pending
モ- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) A 102-05 5 x 1 レmol pending
5- Aminoimidazole- 4- carboxamide- 1- - D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) A 103-10 10 レmol ~2.6 mg 2627-69-2
5- Aminoimidazole- 4- carboxamide- 1- - D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) A 103-50 5 x 10 レmol 2627-69-2
2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) A 104-10 10 レmol ~2.7 mg 10414-81-0
2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) A 104-50 5 x 10 レmol 10414-81-0
5- Aminoimidazole- 4- carboxamide- 1- - D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) A 105-10 10 レmol ~3.4 mg 3031-94-5
5- Aminoimidazole- 4- carboxamide- 1- - D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) A 105-50 5 x 10 レmol 3031-94-5
2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) A 106-05 5 レmol ~2.1 mg 63545-57-3
2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) A 106-25 5 x 5 レmol 63545-57-3
3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) A 107-05 5 レmol ~2.1 mg [4360-06-9]
3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) A 107-25 5 x 5 レmol [4360-06-9]
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108-06 0.6 ml none
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108-25 2.5 ml none
N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108-60 6 ml none
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109-06 0.6 ml none
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109-25 2.5 ml none
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109-60 6 ml none
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110-06 0.6 ml none
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110-25 2.5 ml none
2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110-60 6 ml none
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111-06 0.6 ml none
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111-25 2.5 ml none
N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111-60 6 ml none
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112-06 0.6 ml none
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112-25 2.5 ml none
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112-60 6 ml none
2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) A 113-05 5 レmol ~2.5 mg 61468-88-0
2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) A 113-25 5 x 5 レmol 61468-88-0
3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) A 114-05 5 レmol ~2.5 mg 4209-30-7
3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) A 114-25 5 x 5 レmol 4209-30-7
8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) A 115-05 5 レmol ~2.6 mg 35874-49-8
8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) A 115-25 5 x 5 レmol 35874-49-8
5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) A 116-05 5 レmol ~2.6 mg 85280-65-5
5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) A 116-25 5 x 5 レmol 85280-65-5
5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) A 117-05 5 レmol ~2.7 mg 85280-66-6
5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) A 117-25 5 x 5 レmol 85280-66-6
2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) A 118-05 5 レmol ~2.6 mg pending
2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) A 118-25 5 x 5 レmol pending
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) A 119-05 5 レmol ~2.2 mg pending
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) A 119-25 5 x 5 レmol pending
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) A 120-05 5 レmol ~2.4 mg pending
2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) A 120-25 5 x 5 レmol pending
Adenosine- 5'- O- (2- thiodiphosphate) ( ADP-モ-S ) A 121-05 5 レmol ~2.2 mg 35094-45-2
Adenosine- 5'- O- (2- thiodiphosphate) ( ADP-モ-S ) A 121-25 5 x 5 レmol 35094-45-2
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AEC-cAMPS-Agarose ) A 122-06 0.6 ml none
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AEC-cAMPS-Agarose ) A 122-25 2.5 ml none
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AEC-cAMPS-Agarose ) A 122-60 6 ml none
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) A 123-05 5 レmol ~2.5 mg [1262749-61-0]
2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) A 123-25 5 x 5 レmol [1262749-61-0]
2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) A 124-05 5 レmol ~2.5 mg 23001-60-7
2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) A 124-25 5 x 5 レmol 23001-60-7
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer; immobilized on agarose gel ( Rp-2'-AEC-cAMPS-Agarose ) A 126-06 0.6 ml
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer; immobilized on agarose gel ( Rp-2'-AEC-cAMPS-Agarose ) A 126-25 2.5 ml
2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer; immobilized on agarose gel ( Rp-2'-AEC-cAMPS-Agarose ) A 126-60 6 ml
8- Azido- N6- (2- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) A 127-001 0.1 レmol ~80 レg pending
8- Azido- N6- (2- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) A 127-005 5 x 0.1 レmol pending
8- Aza- N6- nonanoyladenine A 134 inquire 4471-88-9
9- Acetyl- 6- chloroguanine A 135 inquire 149376-70-5
2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) A 136-05 5 レmol ~2.4 mg pending
2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) A 136-25 5 x 5 レmol pending
8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ) A 140-005 0.5 レmol ~309 レg pending
8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ) A 140-025 5 x 0.5 レmol pending
8- (2- Aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-AET-cAMP ) A 141-05 5 レmol 53546-96-6
8- (2- Aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-AET-cAMP ) A 141-25 5 x 5 レmol 53546-96-6
8- (2- Aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AET-2'-O-Me-cAMP ) A 142-05 5 レmol 634207-89-9
8- (2- Aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AET-2'-O-Me-cAMP ) A 142-25 5 x 5 レmol 634207-89-9
N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate ( 4-AH-cCMP ) A 143-05 5 レmol ~2 mg pending
N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate ( 4-AH-cCMP ) A 143-25 5 x 5 レmol pending
8- Aminoadenosine- 5'- O- diphosphate ( 8-NH2-ADP ) A 144-05 5 レmol ~2.2 mg 65312-53-0
8- Aminoadenosine- 5'- O- diphosphate ( 8-NH2-ADP ) A 144-25 5 x 5 レmol 65312-53-0
2'- O- (19- Amino- 4, 7, 10, 13, 16- pentaoxanonadecylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-APNC-cAMP ) A 145-05 5 レmol
2'- O- (19- Amino- 4, 7, 10, 13, 16- pentaoxanonadecylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-APNC-cAMP ) A 145-25 5 x 5 レmol
2'- O- (8- Amino- 3, 6- dioxaoctylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-ADOC-cAMP ) A 146-05 5 レmol
2'- O- (8- Amino- 3, 6- dioxaoctylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-ADOC-cAMP ) A 146-25 5 x 5 レmol
N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cCMP-Agarose ) A 147-06 0.6 ml pending
N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cCMP-Agarose ) A 147-25 2.5 ml pending
N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cCMP-Agarose ) A 147-60 6 ml pending
8- Azaadenosine- 5'- O- monophosphate ( 8-Aza-5'-AMP ) A 149 inquire pending
8- Azaadenosine- 3', 5'- cyclic monophosphate ( 8-Aza-cAMP ) A 150 inquire 67190-31-2
2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-AHC-c-diGMP ) A 151-001 0.1 レmol ~83 レg pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-AHC-c-diGMP ) A 151-005 5 x 0.1 レmol pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) A 153-06 0.6 ml pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) A 153-25 2.5 ml pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) A 153-60 6 ml pending
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AET-cGMPS ) A 154-05 5 レmol 221904-88-7
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AET-cGMPS ) A 154-25 5 x 5 レmol 221904-88-7
2'- / 3'- O- (6- Aminohexylcarbamoyl)uridine- 5'- O- triphosphate ( 2'-/3'-AHC-UTP ) A 155-05 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)uridine- 5'- O- triphosphate ( 2'-/3'-AHC-UTP ) A 155-25 5 x 5 レmol pending
2'- O- (6- Aminohexylcarbamoyl)cytidine- 3', 5'- cyclic monophosphate ( 2'-AHC-cCMP ) A 156-05 5 レmol [pending]
2'- O- (6- Aminohexylcarbamoyl)cytidine- 3', 5'- cyclic monophosphate ( 2'-AHC-cCMP ) A 156-25 5 x 5 レmol [pending]
2'- / 3'- O- (6- Aminohexylcarbamoyl)cytidine- 5'- O- triphosphate ( 2'-/3'-AHC-CTP ) A 157-05 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)cytidine- 5'- O- triphosphate ( 2'-/3'-AHC-CTP ) A 157-25 5 x 5 レmol pending
2'- O- (2- Aminoethylcarbamoyl)cytidine- 3', 5'- cyclic monosposphate, immobilized on agarose gel ( 2'-AHC-cCMP-Agarose ) A 158-06 0.6 ml
2'- O- (2- Aminoethylcarbamoyl)cytidine- 3', 5'- cyclic monosposphate, immobilized on agarose gel ( 2'-AHC-cCMP-Agarose ) A 158-25 2.5 ml
2'- O- (2- Aminoethylcarbamoyl)cytidine- 3', 5'- cyclic monosposphate, immobilized on agarose gel ( 2'-AHC-cCMP-Agarose ) A 158-60 6 ml
8- (6- Aminohexylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AHT-cGMP ) A 167-05 5 レmol ~2.4 mg 144510-13-4
8- (6- Aminohexylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AHT-cGMP ) A 167-25 5 x 5 レmol 144510-13-4
2'- / 3'- O- (2- Aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-AEC-5'-GMP ) A 170-05 5 レmol pending
2'- / 3'- O- (2- Aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-AEC-5'-GMP ) A 170-25 5 x 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'-/3'-AHC-5'-AMP ) A 171-05 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'-/3'-AHC-5'-AMP ) A 171-25 5 x 5 レmol pending
2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'-/3'-AEC-5'-AMP ) A 172-05 5 レmol pending
2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'-/3'-AEC-5'-AMP ) A 172-25 5 x 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-AHC-5'-GMP ) A 174-05 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-AHC-5'-GMP ) A 174-25 5 x 5 レmol pending
Adenosine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( ATP-ャ-AmNS ) A 176-05 5 レmol 66492-86-2
Adenosine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( ATP-ャ-AmNS ) A 176-25 5 x 5 レmol 66492-86-2
P1- (5'- Adenosyl)- P4- (5'- guanosyl)- tetraphosphate ( Ap4G / Gp4A ) A 177-005 0.5 レmol 10527-46-5
P1- (5'- Adenosyl)- P4- (5'- guanosyl)- tetraphosphate ( Ap4G / Gp4A ) A 177-025 5 x 0.5 レmol 10527-46-5
P1- (5'- Adenosyl)- P4- (5'- cytidyl)- tetraphosphate ( Ap4C / Cp4A ) A 178-005 0.5 レmol 1352921-13-1
P1- (5'- Adenosyl)- P4- (5'- cytidyl)- tetraphosphate ( Ap4C / Cp4A ) A 178-025 5 x 0.5 レmol 1352921-13-1
8- Azidoadenosine- 5'- O- monophosphate, sodium salt ( 8-N3-5'-AMP ) A 179-05 5 レmol 60731-47-7
8- Azidoadenosine- 5'- O- monophosphate, sodium salt ( 8-N3-5'-AMP ) A 179-25 5 x 5 レmol 60731-47-7
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AEA-cAMPS ) A 180-05 5 レmol 221904-78-5
8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AEA-cAMPS ) A 180-25 5 x 5 レmol 221904-78-5
2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-AHC-c-diAMP ) A 182-001 0.1 レmol ~80 レg pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-AHC-c-diAMP ) A 182-005 5 x 0.1 レmol pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) A 183-06 0.6 ml pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) A 183-25 2.5 ml pending
2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) A 183-60 6 ml pending
Adenosine- 5'- O- diphospho- (1''- (4- nitrophenoxy)- ribose) ( ADPR-pNP ) A 184-01 1 レmol 939028-75-8
Adenosine- 5'- O- diphospho- (1''- (4- nitrophenoxy)- ribose) ( ADPR-pNP ) A 184-05 5 x 1 レmol 939028-75-8
モ- (4- Azidophenyl)- 1, N2- etheno- 8- (2- [biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-[Biotin]-AET-cGMP ) A 186-001 0.1 レmol
モ- (4- Azidophenyl)- 1, N2- etheno- 8- (2- [biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-[Biotin]-AET-cGMP ) A 186-005 5 x 0.1 レmol
2'- / 3'- O- (6- Aminohexylcarbamoyl)guanosine- 5'- O- triphosphate ( 2'-/3'-AHC-GTP ) A 188-05 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)guanosine- 5'- O- triphosphate ( 2'-/3'-AHC-GTP ) A 188-25 5 x 5 レmol pending
2'- / 3'- O- (6- Aminohexylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AHC-ATP ) A 189-05 5 レmol
2'- / 3'- O- (6- Aminohexylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AHC-ATP ) A 189-25 5 x 5 レmol
Adenosine- 5'- O- diphosphoribose phosphate ( ADPRP ) A 190-05 5 レmol 53595-18-9
Adenosine- 5'- O- diphosphoribose phosphate ( ADPRP ) A 190-25 5 x 5 レmol 53595-18-9
8- (6- Aminohexylthio)guanosine- 5'- O- triphosphate ( 8-AHT-GTP ) A 191-01 1 レmol pending
8- (6- Aminohexylthio)guanosine- 5'- O- triphosphate ( 8-AHT-GTP ) A 191-05 5 x 1 レmol pending
8- (2- Aminoethylthio)guanosine- 5'- O- triphosphate ( 8-AET-GTP ) A 192-05 5 レmol pending
8- (2- Aminoethylthio)guanosine- 5'- O- triphosphate ( 8-AET-GTP ) A 192-25 5 x 5 レmol pending
8- (2- Aminoethylthio)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cAMP-Agarose ) A 193-06 0.6 ml
8- (2- Aminoethylthio)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cAMP-Agarose ) A 193-25 2.5 ml
8- (2- Aminoethylthio)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cAMP-Agarose ) A 193-60 6 ml
8- (2- Aminoethylthio)- 2'-O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-2'-O-Me-cAMP-Agarose ) A 195-06 0.6 ml
8- (2- Aminoethylthio)- 2'-O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-2'-O-Me-cAMP-Agarose ) A 195-25 2.5 ml
8- (2- Aminoethylthio)- 2'-O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-2'-O-Me-cAMP-Agarose ) A 195-60 6 ml
2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cGMP-Agarose ) A 196-06 0.6 ml
2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cGMP-Agarose ) A 196-25 2.5 ml
2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cGMP-Agarose ) A 196-60 6 ml
2'- / 3'- O- Anthraniloyladenosine- 5'- O- triphosphate ( ANT-ATP ) A 197-05 5 レmol 289633-56-3
2'- / 3'- O- Anthraniloyladenosine- 5'- O- triphosphate ( ANT-ATP ) A 197-25 5 x 5 レmol 289633-56-3
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AET-cGMPS ) A 198-05 5 レmol 221904-92-3
8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AET-cGMPS ) A 198-25 5 x 5 レmol 221904-92-3
8- (6- Aminohexylamino)- 2- chloroadenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2-Cl-cAMP ) A 199-05 5 レmol
8- (6- Aminohexylamino)- 2- chloroadenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2-Cl-cAMP ) A 199-25 5 x 5 レmol
8- Azido- 1, N6- ethenoadenosine- 5'- O- diphosphate ( 8-N3-e-ADP ), A 210-05 5 レmol [pending]
8- Azido- 1, N6- ethenoadenosine- 5'- O- diphosphate ( 8-N3-e-ADP ), A 210-25 5 x 5 レmol [pending]
8- Azido- 1, N6- ethenoadenosine- 5'- O- triphosphate ( 8-N3-e-ATP ) A 211-05 5 レmol [pending]
8- Azido- 1, N6- ethenoadenosine- 5'- O- triphosphate ( 8-N3-e-ATP ) A 211-25 5 x 5 レmol [pending]
8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) B 001-05 5 レmol ~2.2 mg 129735-00-8
8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) B 001-25 5 x 5 レmol 129735-00-8
8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) B 002-05 5 レmol ~2.2 mg 127634-20-2
8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) B 002-25 5 x 5 レmol 127634-20-2
8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade B 004-250 5 x 50 レmol 51116-01-9
8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade B 004-50 50 レmol ~22 mg 51116-01-9
8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) B 005-05 5 レmol ~2.3 mg 150418-07-8
8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) B 005-25 5 x 5 レmol 150418-07-8
8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) B 006-10 10 レmol ~4.6 mg 153660-03-8
8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) B 006-50 5 x 10 レmol 153660-03-8
8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade B 007-100 100 レmol ~43 mg 76939-46-3
8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade B 007-500 5 x 100 レmol 76939-46-3
N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) B 008-10 10 レmol ~4.4 mg 32115-08-5
N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) B 008-50 5 x 10 レmol 32115-08-5
N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) B 009-10 10 レmol ~4.6 mg 30275-80-0
N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) B 009-50 5 x 10 レmol 30275-80-0
8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) B 010-05 5 レmol ~2.6 mg 788807-32-9
8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) B 010-25 5 x 5 レmol 788807-32-9
8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) B 012-05 5 レmol ~3 mg 23197-98-0
8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) B 012-25 5 x 5 レmol 23197-98-0
6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) B 013-05 5 レmol ~1.7 mg 78000-56-3
6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) B 013-25 5 x 5 レmol 78000-56-3
8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) B 014-01 1 レmol ~0.5 mg 272445-71-3
8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) B 014-05 5 x 1 レmol 272445-71-3
8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) B 015-10 10 レmol ~4.7 mg 50655-17-9
8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) B 015-50 5 x 10 レmol 50655-17-9
6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) B 016-001 0.1 レmol ~68 レg 339291-51-9
6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) B 016-005 5 x 0.1 レmol 339291-51-9
[6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) B 017-001 0.1 レmol ~69 レg 339291-52-0
[6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) B 017-005 5 x 0.1 レmol 339291-52-0
[6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) B 018-001 0.1 レmol ~76 レg 370091-64-8
[6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) B 018-005 5 x 0.1 レmol 370091-64-8
[6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) B 019-001 0.1 レmol ~78 レg 370091-68-2
[6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) B 019-005 5 x 0.1 レmol 370091-68-2
8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) B 020-01 1 レmol ~0.5 mg 190522-24-8
8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) B 020-05 5 x 1 レmol 190522-24-8
8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) B 021-10 10 レmol ~3.5 mg 13389-03-2
8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) B 021-50 5 x 10 レmol 13389-03-2
8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) B 022-05 5 レmol ~2.2 mg 612513-13-0
8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) B 022-25 5 x 5 レmol 612513-13-0
N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) B 023-05 5 レmol ~2.6 mg 40811-89-0
N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) B 023-25 5 x 5 レmol 40811-89-0
N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) B 024-05 5 レmol ~3 mg 40922-97-2
N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) B 024-25 5 x 5 レmol 40922-97-2
8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) B 025-01 1 レmol ~0.8 mg pending
8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) B 025-05 5 x 1 レmol pending
8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) B 027-10 10 レmol ~3.3 mg 14985-44-5
8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) B 027-50 5 x 10 レmol 14985-44-5
8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-2'-O-Me-cAMP-AM ) B 028-01 1 レmol ~0.5 mg pending
8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-2'-O-Me-cAMP-AM ) B 028-05 5 x 1 レmol pending
8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, acetoxymethyl ester ( Sp-8-Br-cAMPS-AM ) B 029-01 1 レmol ~0.5 mg pending
8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, acetoxymethyl ester ( Sp-8-Br-cAMPS-AM ) B 029-05 5 x 1 レmol pending
8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) B 030-01 1 レmol ~0.8 mg pending
8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) B 030-05 5 x 1 レmol pending
8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-2'-O-Me-cAMPS ) B 031-01 1 レmol ~0.5 mg 634208-34-7
8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-2'-O-Me-cAMPS ) B 031-05 5 x 1 レmol 634208-34-7
N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) B 032-01 1 レmol ~0.8 mg pending
N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) B 032-05 5 x 1 レmol pending
8- Bromoadenosine B 033 Inquire 2946-39-6
8- Bromo- 2'- O- methylguanosine ( 8-Br-2'-O-Me-Guo ) B 034 Inquire 847649-49-4
8- Bromoguanosine B 036 Inquire 4016-63-1
8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) B 037-05 5 レmol ~2.3 mg pending
8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) B 037-25 5 x 5 レmol pending
8- Bromo- 2', 3', 5'- tri- O- acetylguanosine ( 8-Br-2',3',5'-TAc-Guo ) B 038 Inquire 15717-45-0
8- Bromoxanthosine ( 8-Br-Xao ) B 039 Inquire 3001-46-5
N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) B 040-05 5 レmol ~2.4 mg 152218-18-3
N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) B 040-25 5 x 5 レmol 152218-18-3
2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AHA-cAMP ) B 041-01 1 レmol ~0.8 mg pending
2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AHA-cAMP ) B 041-05 5 x 1 レmol pending
O6- Benzylguanosine- 3', 5'- cyclic monophosphate ( 6-Bn-cGMP ) B 043 inquire 205368-46-3
6- Benzylthioguanosine- 3', 5'- cyclic monophosphate ( 6-BT-cGMP ) B 045-01 inquire
8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ) B 051-05 5 レmol ~3.2 mg 59259-77-7
8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ) B 051-25 5 x 5 レmol 59259-77-7
8- Bromoadenine ( 8-Br-Ade ) B 052-10 10 レmol ~2.1 mg 6974-78-3
8- Bromoadenine ( 8-Br-Ade ) B 052-50 5 x 10 レmol 6974-78-3
N6- Benzoyl- 8- piperidinoadenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-8-PIP-cAMP ) B 055-05 5 レmol
N6- Benzoyl- 8- piperidinoadenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-8-PIP-cAMP ) B 055-25 5 x 5 レmol
8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) B 057-10 10 レmol ~4.4 mg 21870-09-7
8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) B 057-50 5 x 10 レmol 21870-09-7
8- Bromoguanine ( 8-Br-Gua ) B 058-10 10 レmol ~2.3 mg 3066-84-0
8- Bromoguanine ( 8-Br-Gua ) B 058-50 5 x 10 レmol 3066-84-0
8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) B 065-005 0.5 レmol ~310 レg 151898-26-9
8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) B 065-025 5 x 0.5 レmol 151898-26-9
8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) B 066-10 10 レmol ~4.3 mg 23567-96-6
8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) B 066-50 5 x 10 レmol 23567-96-6
8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) B 067-05 5 レmol ~2.5 mg 23600-16-0
8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) B 067-25 5 x 5 レmol 23600-16-0
8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) B 068-05 5 レmol ~2.9 mg 23567-97-7
8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) B 068-25 5 x 5 レmol 23567-97-7
8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) B 069-05 5 レmol ~2.9 mg 92410-99-6
8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) B 069-25 5 x 5 レmol 92410-99-6
8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) B 070-05 5 レmol ~2.9 mg 66891-23-4
8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) B 070-25 5 x 5 レmol 66891-23-4
8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) B 071-005 0.5 レmol 311 レg 638195-70-7
8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) B 071-025 5 x 0.5 レmol 638195-70-7
N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-ャ-S ) B 072-05 5 レmol ~3.1 mg 944834-42-8
N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-ャ-S ) B 072-25 5 x 5 レmol 944834-42-8
N6- (3-[ Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-[Biotin]-APr-ADP ) B 076-01 1 レmol ~0.7 mg pending
N6- (3-[ Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-[Biotin]-APr-ADP ) B 076-05 5 x 1 レmol pending
N6- (3- [([ Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-[Biotin]-APrO-(EO)4-Pr-ADP ) B 077-01 1 レmol ~1 mg pending
N6- (3- [([ Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-[Biotin]-APrO-(EO)4-Pr-ADP ) B 077-05 5 x 1 レmol pending
N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) B 079-01 1 レmol ~0.5 mg pending
N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) B 079-05 5 x 1 レmol pending
8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ) B 082-005 0.5 レmol ~320 レg pending
8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ) B 082-025 5 x 0.5 レmol pending
8- Benzylthio- cyclic inosine diphosphate ribose ( 8-BT-N1-cIDPR ) B 085-005 0.5 レmol pending
8- Benzylthio- cyclic inosine diphosphate ribose ( 8-BT-N1-cIDPR ) B 085-025 5 x 0.5 レmol pending
8- (4- tert.- Butylbenzylthio)- cyclic inosine diphosphate ribose ( 8-ptBBT-N1-cIDPR ) B 086-005 0.5 レmol pending
8- (4- tert.- Butylbenzylthio)- cyclic inosine diphosphate ribose ( 8-ptBBT-N1-cIDPR ) B 086-025 5 x 0.5 レmol pending
2', 3'- O- ( Bis- anthraniloyl)adenosine- 5'- O- triphosphate ( Bis-ANT-ATP ) B 090-05 5 レmol [pending]
2', 3'- O- ( Bis- anthraniloyl)adenosine- 5'- O- triphosphate ( Bis-ANT-ATP ) B 090-25 5 x 5 レmol [pending]
2', 3'- O- ( Bis- [5- chloroanthraniloyl])adenosine- 5'- O- triphosphate ( Bis-Cl-ANT-ATP ) B 091-05 5 レmol 1350460-89-7
2', 3'- O- ( Bis- [5- chloroanthraniloyl])adenosine- 5'- O- triphosphate ( Bis-Cl-ANT-ATP ) B 091-25 5 x 5 レmol 1350460-89-7
2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[Biotin]-AHC-c-diGMP ) B 098-001 0.1 レmol ~0.1 mg pending
2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[Biotin]-AHC-c-diGMP ) B 098-005 5 x 0.1 レmol pending
8- Bromo- cyclic diguanosine monophosphate ( 8-Br-c-diGMP ) B 099-001 0.1 レmol ~77 レg pending
8- Bromo- cyclic diguanosine monophosphate ( 8-Br-c-diGMP ) B 099-005 5 x 0.1 レmol pending
8- Bromo- 7- deaza- cyclic adenosine diphosphate ribose ( 8-Br-7-CH-cADPR ) B 100-005 0.5 レmol ~310 レg 189876-06-0
8- Bromo- 7- deaza- cyclic adenosine diphosphate ribose ( 8-Br-7-CH-cADPR ) B 100-025 5 x 0.5 レmol 189876-06-0
8- Bromo- 7- deazaadenosine- 5'- O- diphosphoribose ( 8-Br-7-CH-ADPR ) B 103-005 0.5 レmol pending
8- Bromo- 7- deazaadenosine- 5'- O- diphosphoribose ( 8-Br-7-CH-ADPR ) B 103-025 5 x 0.5 レmol pending
2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-[Biotin]-AHC-c-diAMP ) B 106-001 0.1 レmol ~0.1 mg pending
2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-[Biotin]-AHC-c-diAMP ) B 106-005 5 x 0.1 レmol pending
N6- Benzoyladenosine- 5'- O- monophosphate ( 6-Bnz-5'-AMP ) B 109-05 5 レmol 40871-55-4
N6- Benzoyladenosine- 5'- O- monophosphate ( 6-Bnz-5'-AMP ) B 109-25 5 x 5 レmol 40871-55-4
2', 3'- O- (5- Bromoanthraniloyl)adenosine- 5'- O- triphosphate ( Br-ANT-ATP ) B 110-05 5 レmol 1350521-49-1
2', 3'- O- (5- Bromoanthraniloyl)adenosine- 5'- O- triphosphate ( Br-ANT-ATP ) B 110-25 5 x 5 レmol 1350521-49-1
2', 3'- O- ( Bis- [5- bromoanthraniloyl])adenosine- 5'- O- triphosphate ( Bis-Br-ANT-ATP ) B 111-05 5 レmol 1350460-91-1
2', 3'- O- ( Bis- [5- bromoanthraniloyl])adenosine- 5'- O- triphosphate ( Bis-Br-ANT-ATP ) B 111-25 5 x 5 レmol 1350460-91-1
3- [5- (tert.- Butyl)isoxazol- 3- yl]- 2- [2- (3- chlorophenyl)hydrazono]- 3- oxopropanenitrile ( ESI-09 ) B 133-05 5 レmol 263707-16-0
3- [5- (tert.- Butyl)isoxazol- 3- yl]- 2- [2- (3- chlorophenyl)hydrazono]- 3- oxopropanenitrile ( ESI-09 ) B 133-25 5 x 5 レmol 263707-16-0
Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) C 001-250 5 x 50 レmol 54925-33-6
Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) C 001-50 50 レmol ~16 mg 54925-33-6
6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) C 002-05 5 レmol ~1.9 mg 94200-58-5
6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) C 002-25 5 x 5 レmol 94200-58-5
8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) C 003-05 5 レmol ~2 mg 142754-27-6
8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) C 003-25 5 x 5 レmol 142754-27-6
8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) C 004-05 5 レmol ~2 mg 142754-28-7
8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) C 004-25 5 x 5 レmol 142754-28-7
Cyclic adenosine diphosphate ribose ( cADPR ) C 005-005 0.5 レmol ~270 レg 119340-53-3
Cyclic adenosine diphosphate ribose ( cADPR ) C 005-025 5 x 0.5 レmol 119340-53-3
8- Chloroadenosine ( 8-Cl-Ado ) C 006-10 10 レmol ~3 mg 34408-14-5
8- Chloroadenosine ( 8-Cl-Ado ) C 006-50 5 x 10 レmol 34408-14-5
8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) C 007-10 10 レmol ~3.9 mg 124705-03-9
8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) C 007-50 5 x 10 レmol 124705-03-9
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade C 009-10 10 レmol ~5 mg 51239-26-0
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade C 009-50 5 x 10 レmol 51239-26-0
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade C 010-100 100 レmol ~49 mg 93882-12-3
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade C 010-500 5 x 100 レmol 93882-12-3
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) C 011-05 5 レmol ~2.5 mg 129735-01-9
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) C 011-25 5 x 5 レmol 129735-01-9
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) C 012-05 5 レmol ~2.5 mg 129693-13-6
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) C 012-25 5 x 5 レmol 129693-13-6
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) C 013-01 1 レmol ~0.5 mg 153660-04-9
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) C 013-05 5 x 1 レmol 153660-04-9
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) C 014-05 5 レmol ~2.6 mg 160385-87-5
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) C 014-25 5 x 5 レmol 160385-87-5
6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) C 015-05 5 レmol ~2.2 mg 59128-86-8
6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) C 015-25 5 x 5 レmol 59128-86-8
8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) C 016-05 5 レmol ~1.9 mg 37676-40-7
8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) C 016-25 5 x 5 レmol 37676-40-7
2- Chloroadenosine ( 2-Cl-Ado / 2-CADO ) C 017-100 100 レmol ~30 mg 146-77-0
2- Chloroadenosine ( 2-Cl-Ado / 2-CADO ) C 017-500 5 x 100 レmol 146-77-0
8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) C 018-05 5 レmol ~2.7 mg 185341-71-3
8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) C 018-25 5 x 5 レmol 185341-71-3
8- Chloroinosine ( 8-Cl-Ino ) C 019-05 5 レmol ~1.5 mg 116285-77-9
8- Chloroinosine ( 8-Cl-Ino ) C 019-25 5 x 5 レmol 116285-77-9
2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) C 020-05 5 レmol ~1.9 mg 39023-65-9
2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) C 020-25 5 x 5 レmol 39023-65-9
2- Chloroinosine ( 2-Cl-Ino ) C 021-10 10 レmol ~3 mg 13276-43-2
2- Chloroinosine ( 2-Cl-Ino ) C 021-50 5 x 10 レmol 13276-43-2
N6- Carbamoylthreonyladenosine ( t6-Ado ) C 022-10 10 レmol ~4.3 mg 24719-82-2
N6- Carbamoylthreonyladenosine ( t6-Ado ) C 022-50 5 x 10 レmol 24719-82-2
8- Chloroadenine ( 8-Cl-Ade ) C 023-10 10 レmol ~1.7 mg 28128-28-1
8- Chloroadenine ( 8-Cl-Ade ) C 023-50 5 x 10 レmol 28128-28-1
8- Chloro- 2'- deoxyadenosine ( 8-Cl-dAdo ) C 024-05 5 レmol ~1.4 mg 85562-55-6
8- Chloro- 2'- deoxyadenosine ( 8-Cl-dAdo ) C 024-25 5 x 5 レmol 85562-55-6
8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) C 025-05 5 レmol ~1.5 mg 437715-62-3
8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) C 025-25 5 x 5 レmol 437715-62-3
8- Chloroguanosine ( 8-Cl-Guo ) C 026-05 5 レmol ~1.6 mg 2104-68-9
8- Chloroguanosine ( 8-Cl-Guo ) C 026-25 5 x 5 レmol 2104-68-9
8- Chloroguanine ( 8-Cl-Gua ) C 027-10 10 レmol ~1.9 mg 22052-03-5
8- Chloroguanine ( 8-Cl-Gua ) C 027-50 5 x 10 レmol 22052-03-5
2- Chloro- 2'- deoxyadenosine ( Cladribine, 2-Cl-dAdo, CdA ) C 028-100 100 レmol ~29 mg 4291-63-8
2- Chloro- 2'- deoxyadenosine ( Cladribine, 2-Cl-dAdo, CdA ) C 028-500 5 x 100 レmol 4291-63-8
2- Chloroinosine- 3', 5'- cyclic monophosphate, sodium salt ( 2-Cl-cIMP ) C 029-05 5 レmol ~1.9 mg 52301-30-1
2- Chloroinosine- 3', 5'- cyclic monophosphate, sodium salt ( 2-Cl-cIMP ) C 029-25 5 x 5 レmol 52301-30-1
6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ), sodium salt C 032-10 10 レmol ~3.7 mg 5843-59-4
6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ), sodium salt C 032-50 5 x 10 レmol 5843-59-4
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) C 033-01 1 レmol ~0.6 mg 272445-72-4
8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) C 033-05 5 x 1 レmol 272445-72-4
5- Chlorocytidine ( 5-Cl-C ) C 034-05 5 レmol ~1.4 mg 25130-29-4
5- Chlorocytidine ( 5-Cl-C ) C 034-25 5 x 5 レmol 25130-29-4
5- Chlorouridine ( 5-Cl-U ) C 035-05 5 レmol ~1.4 mg 2880-89-9
5- Chlorouridine ( 5-Cl-U ) C 035-25 5 x 5 レmol 2880-89-9
2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) C 039-05 5 レmol ~2.7 mg 49564-60-5
2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) C 039-25 5 x 5 レmol 49564-60-5
2- Chloroadenine ( 2-Cl-Ade ) C 040-10 10 レmol ~1.7 mg 1839-18-5
2- Chloroadenine ( 2-Cl-Ade ) C 040-50 5 x 10 レmol 1839-18-5
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) C 041-05 5 レmol ~2.5 mg 634207-53-7
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) C 041-25 5 x 5 レmol 634207-53-7
8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-ADP ) C 042-05 5 レmol ~2.3 mg 185341-69-9
8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-ADP ) C 042-25 5 x 5 レmol 185341-69-9
8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) C 043-05 5 レmol ~2.8 mg 72549-36-1
8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) C 043-25 5 x 5 レmol 72549-36-1
8- Chloroxanthine ( 8-Cl-X ) C 044-10 10 レmol ~1.9 mg 13548-68-0
8- Chloroxanthine ( 8-Cl-X ) C 044-50 5 x 10 レmol 13548-68-0
8- (4- Chlorophenylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) C 045-05 5 レmol ~3 mg pending
8- (4- Chlorophenylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) C 045-25 5 x 5 レmol pending
8- (4- Chlorophenylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) C 046-01 1 レmol ~0.6 mg [1262749-62-1]
8- (4- Chlorophenylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) C 046-05 5 x 1 レmol [1262749-62-1]
8- (4- Chlorophenylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) C 047-01 1 レmol ~0.6 mg [1262749-63-2]
8- (4- Chlorophenylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) C 047-05 5 x 1 レmol [1262749-63-2]
8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) C 048-05 5 レmol ~2.6 mg 625112-42-7
8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) C 048-25 5 x 5 レmol 625112-42-7
6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) C 049-05 5 レmol ~2.6 mg 55673-61-5
6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) C 049-25 5 x 5 レmol 55673-61-5
8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) C 050-01 1 レmol ~0.4 mg pending
8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) C 050-05 5 x 1 レmol pending
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-2'-O-Me-cAMP-AM ) C 051-01 1 レmol ~0.6 mg [1152197-23-3]
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-2'-O-Me-cAMP-AM ) C 051-05 5 x 1 レmol [1152197-23-3]
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) C 052-01 1 レmol ~0.5 mg 634208-37-0
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) C 052-05 5 x 1 レmol 634208-37-0
Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ), sodium salt C 053-05 5 レmol ~1.7 mg 47151-76-8
Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ), sodium salt C 053-25 5 x 5 レmol 47151-76-8
2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) C 054-10 10 レmol ~3.8 mg 21466-01-3
2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) C 054-50 5 x 10 レmol 21466-01-3
2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-ADP ) C 055-05 5 レmol ~2.3 mg 16506-88-0
2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-ADP ) C 055-25 5 x 5 レmol 16506-88-0
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) C 056-01 1 レmol ~0.5 mg 663941-66-0
8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) C 056-05 5 x 1 レmol 663941-66-0
Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' ?> 5' ) diguanylic acid C 057-01 1 レmol ~0.7 mg 61093-23-0
Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' ?> 5' ) diguanylic acid C 057-05 5 x 1 レmol 61093-23-0
6- Chloropurine riboside C 058 Inquire 5399-87-1
8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) C 059-05 5 レmol ~2.6 mg pending
8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) C 059-25 5 x 5 レmol pending
8- (4- Chlorophenylthio)guanosine ( 8-pCPT-Guo ) C 060 Inquire pending
N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP / cpADP ) C 061-05 5 レmol ~2.5 mg 681175-79-1
N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP / cpADP ) C 061-25 5 x 5 レmol 681175-79-1
N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) C 062-05 5 レmol ~2.9 mg 189822-11-5
N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) C 062-25 5 x 5 レmol 189822-11-5
Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) C 065-01 1 レmol ~0.3 mg 87063-79-4
Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) C 065-05 5 x 1 レmol 87063-79-4
Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) C 066-05 5 レmol ~1.7 mg 87063-81-8
Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) C 066-25 5 x 5 レmol 87063-81-8
Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) C 067-01 1 レmol ~0.4 mg pending
Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) C 067-05 5 x 1 レmol pending
8- (4- Chlorophenylthio)adenine ( 8-pCPT-Ade ) C 069-10 10 レmol 696574-61-5
8- (4- Chlorophenylthio)adenine ( 8-pCPT-Ade ) C 069-50 5 x 10 レmol 696574-61-5
8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) C 070-10 10 レmol ~4.2 mg 1187179-96-9
8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) C 070-50 5 x 10 レmol 1187179-96-9
2- Chloro- 8- n- hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-HA-cAMP ) C 071-05 5 レmol
2- Chloro- 8- n- hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-HA-cAMP ) C 071-25 5 x 5 レmol
2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2-Cl-cAMPS ) C 073-05 5 レmol 124844-92-4
2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2-Cl-cAMPS ) C 073-25 5 x 5 レmol 124844-92-4
2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-Cl-cAMPS ) C 074-05 5 レmol 124854-63-3
2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-Cl-cAMPS ) C 074-25 5 x 5 レmol 124854-63-3
8- (4- Chlorophenylthio)guanine ( 8-pCPT-Gua ) C 076-10 10 レmol 852657-04-6
8- (4- Chlorophenylthio)guanine ( 8-pCPT-Gua ) C 076-50 5 x 10 レmol 852657-04-6
Cytidine- 5'- O- (メ, モ- methylene)diphosphate ( CMP-CP ) C 077-05 5 レmol ~2 mg 101536-15-6
Cytidine- 5'- O- (メ, モ- methylene)diphosphate ( CMP-CP ) C 077-25 5 x 5 レmol 101536-15-6
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) C 078-05 5 レmol ~2.5 mg 1187179-94-7
8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) C 078-25 5 x 5 レmol 1187179-94-7
Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-モ-S ) C 079-05 5 レmol ~2.1 mg 497064-72-9
Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-モ-S ) C 079-25 5 x 5 レmol 497064-72-9
2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) C 080-05 5 レmol ~2.1 mg 96990-16-8
2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) C 080-25 5 x 5 レmol 96990-16-8
5- Chloro- 2'- deoxycytidine ( 5-Cl-dC / CldC ) C 081-05 5 レmol ~1.3 mg 32387-56-7
5- Chloro- 2'- deoxycytidine ( 5-Cl-dC / CldC ) C 081-25 5 x 5 レmol 32387-56-7
6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Rp- isomer( Rp-6-Cl-cPuMPS ) C 082-05 5 レmol 129693-15-8
6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Rp- isomer( Rp-6-Cl-cPuMPS ) C 082-25 5 x 5 レmol 129693-15-8
6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Cl-cPuMPS ) C 083-05 5 レmol 129693-12-5
6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Cl-cPuMPS ) C 083-25 5 x 5 レmol 129693-12-5
N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) C 084-05 5 レmol ~2.9 mg 206978-73-6
N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) C 084-25 5 x 5 レmol 206978-73-6
N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) C 085-05 5 レmol ~2.5 mg pending
N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) C 085-25 5 x 5 レmol pending
8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) C 086-10 10 レmol ~4.1 mg 85352-87-0
8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) C 086-50 5 x 10 レmol 85352-87-0
Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis (3' ?> 5') diadenylic acid C 088-001 0.1 レmol ~66 レg 54447-84-6
Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis (3' ?> 5') diadenylic acid C 088-005 5 x 0.1 レmol 54447-84-6
Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis (3' ?> 5') diadenylic acid C 088-01 1 レmol 54447-84-6
Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis (3' ?> 5') diadenylic acid C 088-05 5 x 1 レmol 54447-84-6
N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-5'-AMP ) C 089-05 5 レmol ~2.1 mg 117778-38-8
N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-5'-AMP ) C 089-25 5 x 5 レmol 117778-38-8
8- Carboxyethylaminoadenine ( 8-CEA-Ade ) C 091-10 10 レmol pending
8- Carboxyethylaminoadenine ( 8-CEA-Ade ) C 091-50 5 x 10 レmol pending
8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) C 092-10 10 レmol ~3.5 mg 1151916-53-8
8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) C 092-50 5 x 10 レmol 1151916-53-8
Cytidine- 2'- O- monophosphate ( 2'-CMP ) C 093-05 5 レmol 85-94-9
Cytidine- 2'- O- monophosphate ( 2'-CMP ) C 093-25 5 x 5 レmol 85-94-9
Cytidine- 3'- O- monophosphate ( 3'-CMP ) C 094-05 5 レmol 84-52-6
Cytidine- 3'- O- monophosphate ( 3'-CMP ) C 094-25 5 x 5 レmol 84-52-6
Cyclic inosine diphosphate ribose ( N1-cIDPR ) C 098-005 0.5 レmol ~271 レg 856702-89-1
Cyclic inosine diphosphate ribose ( N1-cIDPR ) C 098-025 5 x 0.5 レmol 856702-89-1
8- (4- Chlorophenylthio)- cyclic inosine diphosphate ribose ( 8-pCPT-N1-cIDPR ) C 100-005 0.5 レmol pending
8- (4- Chlorophenylthio)- cyclic inosine diphosphate ribose ( 8-pCPT-N1-cIDPR ) C 100-025 5 x 0.5 レmol pending
8- (4- Chlorophenylthio)adenosine- 5'- O- monophosphate ( 8-pCPT-5'-AMP ) C 101-05 5 レmol ~2.4 mg 78710-84-6
8- (4- Chlorophenylthio)adenosine- 5'- O- monophosphate ( 8-pCPT-5'-AMP ) C 101-25 5 x 5 レmol 78710-84-6
8- (4- Chlorophenylthio)- 2'- O- methylguanosine ( 8-pCPT-2'-O-Me-Guo ) C 102-05 5 レmol ~2.2 mg 956935-50-5
8- (4- Chlorophenylthio)- 2'- O- methylguanosine ( 8-pCPT-2'-O-Me-Guo ) C 102-25 5 x 5 レmol 956935-50-5
Cyclic diinosine monophosphate ( c-diIMP ) C 105-001 1 レmol ~0.7 mg 79940-41-3
Cyclic diinosine monophosphate ( c-diIMP ) C 105-005 5 x 1 レmol 79940-41-3
Cytidine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( CTP-ャ-AmNS ) C 106-05 5 レmol 84230-52-4
Cytidine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( CTP-ャ-AmNS ) C 106-25 5 x 5 レmol 84230-52-4
2'- (5- Carboxypentylcarbamoyl)adenosine-3', 5'-cyclic monophosphate ( 2'-CPC-cAMP ) C 109-05 5 レmol
2'- (5- Carboxypentylcarbamoyl)adenosine-3', 5'-cyclic monophosphate ( 2'-CPC-cAMP ) C 109-25 5 x 5 レmol
P1- (5'- Cytidyl)- P4- (5'- guanosyl)- tetraphosphate ( Cp4G / Gp4C ) C 112-005 0.5 レmol 79695-24-2
P1- (5'- Cytidyl)- P4- (5'- guanosyl)- tetraphosphate ( Cp4G / Gp4C ) C 112-025 5 x 0.5 レmol 79695-24-2
8- Chloro-2'-O-(fluoresceindiacetate-(2-aminoethylcarbamoyl))adenosine-3', 5'-cyclic monophosphate ( 8-Cl-2'-FDA-AEC-cAMP ) C 113 inquire
2'- / 3'- O- (5- Chloroanthraniloyl)adenosine- 5'- O- triphosphate ( Cl-ANT-ATP ) C 114-05 5 レmol 1350521-45-7
2'- / 3'- O- (5- Chloroanthraniloyl)adenosine- 5'- O- triphosphate ( Cl-ANT-ATP ) C 114-25 5 x 5 レmol 1350521-45-7
N6- Cyclopentyladenosine- 5'- O- (3- thiotriphosphate) ( 6-cPe-ATP-ャ-S ) C 116-05 5 レmol [pending]
N6- Cyclopentyladenosine- 5'- O- (3- thiotriphosphate) ( 6-cPe-ATP-ャ-S ) C 116-25 5 x 5 レmol [pending]
Cyclic (adenosine monophosphate- guanosine monophosphate) ( c-(ApGp) ) C 117-001 0.1 レmol 849214-04-6
Cyclic (adenosine monophosphate- guanosine monophosphate) ( c-(ApGp) ) C 117-005 5 x 0.1 レmol 849214-04-6
N6- Cyclohexyladenosine- 5'- O- (3- thiotriphosphate) ( 6-cHe-ATP-ャ-S) C 127-05 5 レmol pending
N6- Cyclohexyladenosine- 5'- O- (3- thiotriphosphate) ( 6-cHe-ATP-ャ-S) C 127-25 5 x 5 レmol pending
Cytidine- 5'- O- diphosphate, immobilized on agarose ( CDP-Agarose ) C 128-06 0.6 ml [pending]
Cytidine- 5'- O- diphosphate, immobilized on agarose ( CDP-Agarose ) C 128-25 2.5 ml [pending]
Cytidine- 5'- O- diphosphate, immobilized on agarose ( CDP-Agarose ) C 128-60 6 ml [pending]
2'- / 3'- O- (5- Chloroanthraniloyl)inosine- 5'- O- triphosphate ( Cl-ANT-ITP ) C 132-05 5 レmol ~3.3 mg [1350521-48-0]
2'- / 3'- O- (5- Chloroanthraniloyl)inosine- 5'- O- triphosphate ( Cl-ANT-ITP ) C 132-25 5 x 5 レmol [1350521-48-0]
4- Cyclopentyl- 2- (2, 5- dimethylbenzylsulfanyl)- 6- oxo- 1, 6- dihydropyrimidine- 5- carbonitrile ( HJC0197 ) C 136-05 5 レmol 1383539-73-8
4- Cyclopentyl- 2- (2, 5- dimethylbenzylsulfanyl)- 6- oxo- 1, 6- dihydropyrimidine- 5- carbonitrile ( HJC0197 ) C 136-25 5 x 5 レmol 1383539-73-8
5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) D 001-05 5 レmol ~1.8 mg 142754-31-2
5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) D 001-25 5 x 5 レmol 142754-31-2
2', 3'- Dideoxyadenosine ( ddA ) D 002-125 5 x 25 レmol 4097-22-7
2', 3'- Dideoxyadenosine ( ddA ) D 002-25 25 レmol ~5.9 mg 4097-22-7
2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) D 003-05 5 レmol ~1.7 mg 64145-26-2
2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) D 003-25 5 x 5 レmol 64145-26-2
2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-メ-S ) D 004-05 5 レmol ~2.1 mg 120496-69-7
2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-メ-S ) D 004-25 5 x 5 レmol 120496-69-7
2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-メ-S ) D 005-05 5 レmol ~2.1 mg 120496-69-7
2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-メ-S ) D 005-25 5 x 5 レmol 120496-69-7
2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-メ-S ) D 006-05 5 レmol ~2.5 mg 87358-15-4
2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-メ-S ) D 006-25 5 x 5 レmol 87358-15-4
2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-メ-S ) D 007-05 5 レmol ~2.5 mg 80875-87-2
2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-メ-S ) D 007-25 5 x 5 レmol 80875-87-2
N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) D 008-01 1 レmol ~0.5 mg 159910-48-2
N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) D 008-05 5 x 1 レmol 159910-48-2
N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade D 009-100 100 レmol ~49 mg 16980-89-5
N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade D 009-250 E 5 x 50 mg 16980-89-5
N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade D 009-50 E 50 mg ~102 レmol 16980-89-5
N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade D 009-500 5 x 100 レmol 16980-89-5
N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) D 010-250 5 x 50 レmol 51116-00-8
N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) D 010-50 50 レmol ~25 mg 51116-00-8
5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) D 011-10 10 レmol ~4 mg 129693-10-3
5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) D 011-50 5 x 10 レmol 129693-10-3
5, 6- Dichloro- 1- - D- ribofuranosyl benzimidazole ( DRB ) D 012-100 100 レmol ~32 mg 53-85-0
5, 6- Dichloro- 1- - D- ribofuranosyl benzimidazole ( DRB ) D 012-500 5 x 100 レmol 53-85-0
5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) D 013-05 5 レmol ~2.1 mg 120912-55-2
5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) D 013-25 5 x 5 レmol 120912-55-2
5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) D 014-05 5 レmol ~2.1 mg 120912-54-1
5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) D 014-25 5 x 5 レmol 120912-54-1
2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) D 015-10 10 レmol ~3.4 mg 93839-95-3
2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) D 015-50 5 x 10 レmol 93839-95-3
N, N- Dimethylguanosine ( M22Guo ) D 016-100 100 レmol ~31 mg 2140-67-2
N, N- Dimethylguanosine ( M22Guo ) D 016-500 5 x 100 レmol 2140-67-2
2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) D 018-05 5 レmol ~2.4 mg 132619-65-9
2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) D 018-25 5 x 5 レmol 132619-65-9
2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) D 019-05 5 レmol ~2.5 mg 68726-28-3
2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) D 019-25 5 x 5 レmol 68726-28-3
2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) D 020-10 10 レmol ~3.5 mg 93919-42-7
2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) D 020-50 5 x 10 レmol 93919-42-7
7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) D 021-05 5 レmol ~1.8 mg 16719-36-1
7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) D 021-25 5 x 5 レmol 16719-36-1
2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) D 022-05 5 レmol ~1.5 mg 88847-89-6
2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) D 022-25 5 x 5 レmol 88847-89-6
2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate) ( ddGTP-メ-S ) D 025-05 5 レmol ~2.5 mg 154771-50-3
2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate) ( ddGTP-メ-S ) D 025-25 5 x 5 レmol 154771-50-3
2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate) ( ddATP-メ-S ) D 026-05 5 レmol ~2.5 mg 154902-26-8
2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate) ( ddATP-メ-S ) D 026-25 5 x 5 レmol 154902-26-8
2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate) ( ddCTP-メ-S ) D 027-05 5 レmol ~2.4 mg 154771-49-0
2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate) ( ddCTP-メ-S ) D 027-25 5 x 5 レmol 154771-49-0
2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate) ( ddUTP-メ-S ) D 028-05 5 レmol ~2.3 mg 1053668-88-4
2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate) ( ddUTP-メ-S ) D 028-25 5 x 5 レmol 1053668-88-4
3'- Deoxythymidine- 5'- O- (1- thiotriphosphate) ( dTTP-メ-S ) / 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate) ( ddTTP-メ-S ) D 029-05 5 レmol ~2.4 mg 154771-48-9
3'- Deoxythymidine- 5'- O- (1- thiotriphosphate) ( dTTP-メ-S ) / 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate) ( ddTTP-メ-S ) D 029-25 5 x 5 レmol 154771-48-9
2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-メ-S ) D 030-05 5 レmol ~2.6 mg 80902-29-0
2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-メ-S ) D 030-25 5 x 5 レmol 80902-29-0
2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-メ-S ) D 031-05 5 レmol ~2.6 mg 80902-28-9
2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-メ-S ) D 031-25 5 x 5 レmol 80902-28-9
7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP / 5'-TuMP ), sodium salt D 032-10 10 レmol ~3.5 mg 16719-46-3
7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP / 5'-TuMP ), sodium salt D 032-50 5 x 10 レmol 16719-46-3
7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) D 033-05 5 レmol ~2.5 mg 67460-15-5
7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) D 033-25 5 x 5 レmol 67460-15-5
2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) D 037-05 5 レmol ~2.3 mg 132619-66-0
2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) D 037-25 5 x 5 レmol 132619-66-0
3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- O- triphosphate ( ddTTP ) D 038-05 5 レmol ~2.3 mg 128524-26-5
3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- O- triphosphate ( ddTTP ) D 038-25 5 x 5 レmol 128524-26-5
2', 3'- Dideoxyguanosine ( ddG ) D 039-250 5 x 50 レmol 085326-06-3
2', 3'- Dideoxyguanosine ( ddG ) D 039-50 50 レmol ~13 mg 085326-06-3
3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) D 040-100 100 レmol ~23 mg [3416-05-5]??
3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) D 040-500 5 x 100 レmol [3416-05-5]??
3'- Deoxyguanosine ( 3'-dG ) D 041-250 5 x 50 レmol 3608-58-0
3'- Deoxyguanosine ( 3'-dG ) D 041-50 50 レmol ~13 mg 3608-58-0
(7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) D 042-001 0.1 レmol ~58 レg 339291-37-1
(7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) D 042-005 5 x 0.1 レmol 339291-37-1
(7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) D 043-001 0.1 レmol ~63 レg 339291-42-8
(7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) D 043-005 5 x 0.1 レmol 339291-42-8
(7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) D 044-001 0.1 レmol ~60 レg
(7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) D 044-005 5 x 0.1 レmol
(7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) D 045-001 0.1 レmol ~60 レg
(7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) D 045-005 5 x 0.1 レmol
2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-メ-S ) D 046-05 5 レmol ~2.4 mg 80951-76-4
2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-メ-S ) D 046-25 5 x 5 レmol 80951-76-4
2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-メ-S ) D 047-05 5 レmol ~2.4 mg 80951-75-3
2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-メ-S ) D 047-25 5 x 5 レmol 80951-75-3
2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-メ-S ) D 048-05 5 レmol ~2.4 mg 876068-86-9
2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-メ-S ) D 048-25 5 x 5 レmol 876068-86-9
2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-メ-S ) D 049-05 5 レmol ~2.4 mg 876068-87-0
2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-メ-S ) D 049-25 5 x 5 レmol 876068-87-0
2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) D 050-05 5 レmol ~1.3 mg 62471-63-0
2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) D 050-25 5 x 5 レmol 62471-63-0
PKG inhibitor peptide DT-2 D 051-005 0.5 mg ~0.18 レmol pending
PKG inhibitor peptide DT-2 D 051-025 5 x 0.5 mg pending
PKG inhibitor peptide DT-3 D 052-005 0.5 mg ~0.15 レmol pending
PKG inhibitor peptide DT-3 D 052-025 5 x 0.5 mg pending
P1, P2- Di- (adenosine- 5')- diphosphate ( Ap2A / AppA ) D 054-005 0.5 レmol 85065-24-3
P1, P2- Di- (adenosine- 5')- diphosphate ( Ap2A / AppA ) D 054-025 5 x 0.5 レmol 85065-24-3
P1, P5- Di- (adenosine- 5')- pentaphosphate ( Ap5A / ApppppA ) D 055-005 0.5 レmol [4097-04-5]???
P1, P5- Di- (adenosine- 5')- pentaphosphate ( Ap5A / ApppppA ) D 055-025 5 x 0.5 レmol [4097-04-5]???
2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) D 056-05 5 レmol ~1.8 mg 87358-26-7
2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) D 056-25 5 x 5 レmol 87358-26-7
2'- Deoxyuridine- 5'- O- monophosphorothioate ( 5'-dUMPS ) D 057-05 5 レmol ~1.6 mg 205379-91-5
2'- Deoxyuridine- 5'- O- monophosphorothioate ( 5'-dUMPS ) D 057-25 5 x 5 レmol 205379-91-5
7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP / 5'-dTuMP ) D 058-05 5 レmol ~1.7 mg 103078-56-4
7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP / 5'-dTuMP ) D 058-25 5 x 5 レmol 103078-56-4
2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) D 059-05 5 レmol ~1.6 mg 64145-27-3
2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) D 059-25 5 x 5 レmol 64145-27-3
2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) D 060-05 5 レmol ~1.7 mg 771477-45-3
2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) D 060-25 5 x 5 レmol 771477-45-3
7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP / 5'-dTuDP ) D 061-05 5 レmol ~2.1 mg 187478-96-2
7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP / 5'-dTuDP ) D 061-25 5 x 5 レmol 187478-96-2
2'- Deoxyinosine D 062 Inquire 890-38-0
2, 6- Dichloro- 2', 3', 5'- triacetylpurine riboside D 063 Inquire 3056-18-6
2, 6- Dichloropurine riboside D 064 Inquire 13276-52-3
2'- Deoxyguanosine D 065 Inquire 961-07-9
4, 6- Dinitrobenzimidazole riboside- 3', 5'- cyclic monophosphate (4,6-DN-cBIMP) D 069 inquire pending
2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-dcAMP ) D 073-05 5 レmol ~1.8 mg 81356-81-2
2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-dcAMP ) D 073-25 5 x 5 レmol 81356-81-2
2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) D 074-05 5 レmol ~2.5 mg 73449-07-7
2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) D 074-25 5 x 5 レmol 73449-07-7
N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) D 075-10 10 レmol ~4.7 mg 64649-87-2
N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) D 075-50 5 x 10 レmol 64649-87-2
3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) D 076-05 5 レmol ~1.3 mg 67313-23-9
3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) D 076-25 5 x 5 レmol 67313-23-9
2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ュ-5'-dAMP ) D 077-05 5 レmol ~1.8 mg 60508-81-8
2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ュ-5'-dAMP ) D 077-25 5 x 5 レmol 60508-81-8
2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ュ-dATP ) D 078-05 5 レmol ~2.6 mg 81004-54-8
2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ュ-dATP ) D 078-25 5 x 5 レmol 81004-54-8
2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) D 079-05 5 レmol ~1.3 mg 64183-27-3
2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) D 079-25 5 x 5 レmol 64183-27-3
2'- Deoxy- 1, N6- ethenoadenosine ( ュ-dAdo ) D 080-05 5 レmol ~1.4 mg 68498-25-9
2'- Deoxy- 1, N6- ethenoadenosine ( ュ-dAdo ) D 080-25 5 x 5 レmol 68498-25-9
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP ) D 081-05 5 レmol ~2.3 mg pending
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP ) D 081-25 5 x 5 レmol pending
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) D 082-05 5 レmol ~2.4 mg pending
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) D 082-25 5 x 5 レmol pending
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) D 083-05 5 レmol ~2.7 mg 91828-83-0
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) D 083-25 5 x 5 レmol 91828-83-0
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) D 084-05 5 レmol ~2.8 mg 127383-33-9
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) D 084-25 5 x 5 レmol 127383-33-9
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) D 085-05 5 レmol ~3.1 mg 128113-53-1
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) D 085-25 5 x 5 レmol 128113-53-1
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) D 086-05 5 レmol ~3.2 mg 124615-99-2
2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) D 086-25 5 x 5 レmol 124615-99-2
8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP / 8-DY547-cGMP ) D 087-001 0.1 レmol ~0.1 mg pending
8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP / 8-DY547-cGMP ) D 087-005 5 x 0.1 レmol pending
8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) D 089-001 0.1 レmol ~0.1 mg pending
8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) D 089-005 5 x 0.1 レmol pending
8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) D 090-001 0.1 レmol ~0.1 mg pending
8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) D 090-005 5 x 0.1 レmol pending
7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP / 5'-TuDP ) D 091-05 5 レmol ~2.1 mg 21080-53-5
7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP / 5'-TuDP ) D 091-25 5 x 5 レmol 21080-53-5
2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) D 092-05 5 レmol ~2.1 mg 16174-58-6
2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) D 092-25 5 x 5 レmol 16174-58-6
2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) D 093-05 5 レmol 1.9 mg 4682-43-3
2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) D 093-25 5 x 5 レmol 4682-43-3
2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) D 094-05 5 レmol ~2.1 mg 16174-59-7
2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) D 094-25 5 x 5 レmol 16174-59-7
7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) D 096-05 5 レmol ~2.5 mg 10058-66-9
7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) D 096-25 5 x 5 レmol 10058-66-9
7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) D 099-05 5 レmol ~1.8 mg 81611-03-2
7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) D 099-25 5 x 5 レmol 81611-03-2
2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) D 101-001 0.1 レmol ~0.1 mg pending
2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) D 101-005 5 x 0.1 レmol pending
2'- Deoxy- N6- (2- phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-dATP ) D 104-05 5 レmol 1239610-11-7
2'- Deoxy- N6- (2- phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-dATP ) D 104-25 5 x 5 レmol 1239610-11-7
8- Dimethylamino- cyclic inosine diphosphate ribose ( 8-DMA-N1-cIDPR ) D 108-005 0.5 レmol pending
8- Dimethylamino- cyclic inosine diphosphate ribose ( 8-DMA-N1-cIDPR ) D 108-025 5 x 0.5 レmol pending
8- (2- [ DY-547]- aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cAMP / fcAMP ) D 109-001 0.1 レmol ~0.1 mg pending
8- (2- [ DY-547]- aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cAMP / fcAMP ) D 109-005 5 x 0.1 レmol pending
PKG inhibitor peptide (D)-DT-2 D 110-005 0.5 mg ~0.18 レmol pending
PKG inhibitor peptide (D)-DT-2 D 110-025 5 x 0.5 mg pending
2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) D 111-001 0.1 レmol ~0.2 mg pending
2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) D 111-005 5 x 0.1 レmol pending
2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) D 112-001 0.1 レmol ~97 レg pending
2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) D 112-005 5 x 0.1 レmol pending
8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) D 113-001 0.1 レmol ~85 レg 1357147-61-5
8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) D 113-005 5 x 0.1 レmol 1357147-61-5
6- (- D- 2- Deoxyribofuranosyl)- 3, 4- dihydro- 8H- pyrimido- [4, 5- c]- [1, 2]- oxazin- 7- one- 5'- O- triphosphate ( 2'-Deoxy-P-nucleoside-5'-O-triphosphate / dPTP ) D 114-05 5 レmol 173964-83-5
6- (- D- 2- Deoxyribofuranosyl)- 3, 4- dihydro- 8H- pyrimido- [4, 5- c]- [1, 2]- oxazin- 7- one- 5'- O- triphosphate ( 2'-Deoxy-P-nucleoside-5'-O-triphosphate / dPTP ) D 114-25 5 x 5 レmol 173964-83-5
P1, P4- Di- (adenosine- 5')- tetraphosphate ( Ap4A / AppppA ) D 115-01 1 レmol 5542-28-9
P1, P4- Di- (adenosine- 5')- tetraphosphate ( Ap4A / AppppA ) D 115-05 5 x 1 レmol 5542-28-9
2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) D 116-001 0.1 レmol ~0.1 mg pending
2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) D 116-005 5 x 0.1 レmol pending
P1, P3- Di- (adenosine- 5')- triphosphate ( Ap3A / ApppA ) D 117-005 0.5 レmol 5959-90-0
P1, P3- Di- (adenosine- 5')- triphosphate ( Ap3A / ApppA ) D 117-025 5 x 0.5 レmol 5959-90-0
P1, P4- Di- (guanosine- 5')- tetraphosphate ( Gp4G / GppppG ) D 119-005 0.5 レmol 4130-19-2
P1, P4- Di- (guanosine- 5')- tetraphosphate ( Gp4G / GppppG ) D 119-025 5 x 0.5 レmol 4130-19-2
2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) D 121-001 0.1 レmol ~94 レg pending
2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) D 121-005 5 x 0.1 レmol pending
2', 2''- O- ( Di- (6- [biotinyl]aminohexylcarbamoyl))- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) D 122-001 0.1 レmol ~0.2 mg pending
2', 2''- O- ( Di- (6- [biotinyl]aminohexylcarbamoyl))- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) D 122-005 5 x 0.1 レmol pending
P1, P2- Di- (cytidine- 5')- diphosphate ( Cp2C / CppC ) D 127-005 0.5 レmol 29789-88-6
P1, P2- Di- (cytidine- 5')- diphosphate ( Cp2C / CppC ) D 127-025 5 x 0.5 レmol 29789-88-6
P1, P2- Di- (uridine- 5')- diphosphate ( Up2U / UppU ) D 128-005 0.5 レmol 26184-65-6
P1, P2- Di- (uridine- 5')- diphosphate ( Up2U / UppU ) D 128-025 5 x 0.5 レmol 26184-65-6
P1, P4- Di- (uridine- 5')- tetraphosphate ( Up4U / UppppU ) D 129-005 0.5 レmol 59985-21-6
P1, P4- Di- (uridine- 5')- tetraphosphate ( Up4U / UppppU ) D 129-025 5 x 0.5 レmol 59985-21-6
2'-O-(6-[DY505-05]- aminohexylcarbamoyl))guanosine-3',5'-cyclic monophosphate ( 2'-[DY-505-05]-AHC-cGMP ) D 135-001 0.1 レmol [pending]
2'-O-(6-[DY505-05]- aminohexylcarbamoyl))guanosine-3',5'-cyclic monophosphate ( 2'-[DY-505-05]-AHC-cGMP ) D 135-005 5 x 0.1 レmol [pending]
2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) D 136-001 0.1 レmol ~72 レg 849214-02-4
2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) D 136-005 5 x 0.1 レmol 849214-02-4
2'-, 2''- O- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) D 139-001 0.1 レmol 60307-63-3
2'-, 2''- O- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) D 139-005 5 x 0.1 レmol 60307-63-3
- ara- 2'- Deoxy- 2'- fluoro- nicotinamide adenine dinucleotide ( ara-2'-F-NAD+ ) D 148-001 0.1 レmol pending
- ara- 2'- Deoxy- 2'- fluoro- nicotinamide adenine dinucleotide ( ara-2'-F-NAD+ ) D 148-005 5 x 0.1 レmol pending
1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ュ-cAMP ) E 001-10 10 レmol ~3.8 mg 103213-51-0
1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ュ-cAMP ) E 001-50 5 x 10 レmol 103213-51-0
1, N6- Ethenoadenosine- 5'- O- triphosphate ( ュ-ATP ) E 004-05 5 レmol ~2.7 mg 60777-99-3
1, N6- Ethenoadenosine- 5'- O- triphosphate ( ュ-ATP ) E 004-25 5 x 5 レmol 60777-99-3
1, N6- Ethenoadenosine- 5'- O- monophosphate ( ュ-5'-AMP ) E 005-10 10 レmol 103213-41-8
1, N6- Ethenoadenosine- 5'- O- monophosphate ( ュ-5'-AMP ) E 005-250 5 x 50 レmol 103213-41-8
1, N6- Ethenoadenosine- 5'- O- monophosphate ( ュ-5'-AMP ) E 005-50 50 レmol ~21 mg 103213-41-8
1, N6- Ethenoadenosine- 5'- O- diphosphate ( ュ-ADP ) E 007-05 5 レmol ~2.3 mg 103213-52-1
1, N6- Ethenoadenosine- 5'- O- diphosphate ( ュ-ADP ) E 007-25 5 x 5 レmol 103213-52-1
Ethanolamine; immobilized on agarose gel ( EtOH-NH-Agarose ) E 010-06 0.6 ml pending
Ethanolamine; immobilized on agarose gel ( EtOH-NH-Agarose ) E 010-25 2.5 ml pending
Ethanolamine; immobilized on agarose gel ( EtOH-NH-Agarose ) E 010-60 6 ml pending
1, N6- Ethenoadenosine ( ュ-Ado ) E 011-10 10 レmol ~2.9 mg 39007-51-7
1, N6- Ethenoadenosine ( ュ-Ado ) E 011-50 5 x 10 レmol 39007-51-7
1, N6- Ethenoadenine ( ュ-Ade ) E 012-10 10 レmol ~1.6 mg 13875-63-3
1, N6- Ethenoadenine ( ュ-Ade ) E 012-50 5 x 10 レmol 13875-63-3
1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( ュ-ADPR / ュ-ADP-ribose ) E 013-10 10 レmol ~5.8 mg 69699-76-9
1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( ュ-ADPR / ュ-ADP-ribose ) E 013-50 5 x 10 レmol 69699-76-9
1, N6- Ethenoadenosine- 5'- O- diphosphoribose phosphate ( ュ-ADPRP ) E 016-05 5 レmol ~3.3 mg 98088-66-5
1, N6- Ethenoadenosine- 5'- O- diphosphoribose phosphate ( ュ-ADPRP ) E 016-25 5 x 5 レmol 98088-66-5
8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cGMP / 8-[Fluo]-AET-cGMP ) F 001-01 1 レmol ~0.8 mg pending
8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cGMP / 8-[Fluo]-AET-cGMP ) F 001-05 5 x 1 レmol pending
8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cAMP / 8-[Fluo]-AET-cAMP ) F 002-01 1 レmol ~0.8 mg 293296-57-8
8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cAMP / 8-[Fluo]-AET-cAMP ) F 002-05 5 x 1 レmol 293296-57-8
2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP / FAM-cAMP ) F 003-01 1 レmol ~0.9 mg pending
2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP / FAM-cAMP ) F 003-05 5 x 1 レmol pending
2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP / FAM-cGMP ) F 004-01 1 レmol ~0.9 mg pending
2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP / FAM-cGMP ) F 004-05 5 x 1 レmol pending
N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ) F 006-05 5 レmol ~2.5 mg pending
N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ) F 006-25 5 x 5 レmol pending
N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ) F 007-05 5 レmol ~2.9 mg pending
N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ) F 007-25 5 x 5 レmol pending
N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-ャ-S ) F 008-05 5 レmol ~3 mg pending
N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-ャ-S ) F 008-25 5 x 5 レmol pending
2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) F 009-001 0.1 レmol ~0.1 mg pending
2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) F 009-005 5 x 0.1 レmol pending
2'- / 3'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'- / 3'-Fluo-AHC-5'-AMP ) F 010-01 1 レmol ~0.8 mg pending
2'- / 3'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'- / 3'-Fluo-AHC-5'-AMP ) F 010-05 5 x 1 レmol pending
2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) F 011-001 0.1 レmol ~0.1 mg pending
2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) F 011-005 5 x 0.1 レmol pending
8- (6- [ Fluoresceinyl]aminohexylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-AHT-PET-cGMP ) F 012-01 1 レmol [pending]
8- (6- [ Fluoresceinyl]aminohexylthio)- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-AHT-PET-cGMP ) F 012-05 5 x 1 レmol [pending]
Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) G 001-100 100 レmol ~37 mg 40732-48-7
Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) G 001-500 5 x 100 レmol 40732-48-7
Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) G 002-01 1 レmol ~0.4 mg 164007-71-0
Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) G 002-05 5 x 1 レmol 164007-71-0
Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-メ-S ) G 012-05 5 レmol ~2.3 mg 71481-44-2
Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-メ-S ) G 012-25 5 x 5 レmol 71481-44-2
Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-メ-S ) G 013-05 5 レmol ~2.3 mg 71481-45-3
Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-メ-S ) G 013-25 5 x 5 レmol 71481-45-3
Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-メ-S ) G 014-05 5 レmol ~2.7 mg 81570-50-5
Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-メ-S ) G 014-25 5 x 5 レmol 81570-50-5
Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-メ-S ) G 015-05 5 レmol ~2.7 mg 81570-51-6
Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-メ-S ) G 015-25 5 x 5 レmol 81570-51-6
Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) G 016-05 5 レmol ~1.9 mg 86562-09-6
Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) G 016-25 5 x 5 レmol 86562-09-6
Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) G 017-05 5 レmol ~1.9 mg 86562-10-9
Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) G 017-25 5 x 5 レmol 86562-10-9
Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) G 018-10 10 レmol ~3.8 mg 76310-16-2
Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) G 018-50 5 x 10 レmol 76310-16-2
Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-ャ-S ) G 019-05 5 レmol ~2.7 mg 37589-80-3
Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-ャ-S ) G 019-25 5 x 5 レmol 37589-80-3
Guanosine- 3'- O- monophosphate ( 3'-GMP ) G 021-10 10 レmol 6027-83-4
Guanosine- 3'- O- monophosphate ( 3'-GMP ) G 021-50 5 x 10 レmol 6027-83-4
Guanosine- 2'- O- monophosphate ( 2'-GMP ) G 022-10 10 レmol 130-50-7
Guanosine- 2'- O- monophosphate ( 2'-GMP ) G 022-50 5 x 10 レmol 130-50-7
Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-モ-S ) G 023-05 5 レmol ~2.3 mg 71376-97-1
Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-モ-S ) G 023-25 5 x 5 レmol 71376-97-1
Guanosine- 5'- O- (メ, モ- methylene)diphosphate ( GMP-CP ) G 024-05 5 レmol ~2.2 mg 32381-15-0
Guanosine- 5'- O- (メ, モ- methylene)diphosphate ( GMP-CP ) G 024-25 5 x 5 レmol 32381-15-0
Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ) G 025-250 5 x 50 レmol 15718-49-7
Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ) G 025-50 50 レmol ~18 mg 15718-49-7
Guanosine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( GTP-ャ-AmNS ) G 026-05 5 レmol 76724-84-0
Guanosine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( GTP-ャ-AmNS ) G 026-25 5 x 5 レmol 76724-84-0
P1- (5'- Guanosyl)- P4- (5'- uridyl)- tetraphosphate ( Gp4U / Up4G ) G 027-005 0.5 レmol 79695-25-3
P1- (5'- Guanosyl)- P4- (5'- uridyl)- tetraphosphate ( Gp4U / Up4G ) G 027-025 5 x 0.5 レmol 79695-25-3
Guanosine- 5'- O- diphosphate, immobilized on agarose ( GDP-Agarose ) G 028-06 0.6 ml [pending]
Guanosine- 5'- O- diphosphate, immobilized on agarose ( GDP-Agarose ) G 028-25 2.5 ml [pending]
Guanosine- 5'- O- diphosphate, immobilized on agarose ( GDP-Agarose ) G 028-60 6 ml [pending]
8- Hydroxyguanosine ( 8-OH-Guo ) H 001-05 5 レmol ~1.5 mg 3868-31-3
8- Hydroxyguanosine ( 8-OH-Guo ) H 001-25 5 x 5 レmol 3868-31-3
8- Hydroxyguanine ( 8-OH-Gua ) H 002-100 100 レmol ~17 mg 5614-64-2
8- Hydroxyguanine ( 8-OH-Gua ) H 002-500 5 x 100 レmol 5614-64-2
8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) H 003-05 5 レmol ~1.8 mg 31356-95-3
8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) H 003-25 5 x 5 レmol 31356-95-3
8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) H 004-01 1 レmol ~0.4 mg 475084-30-1
8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) H 004-05 5 x 1 レmol 475084-30-1
8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) H 005-05 5 レmol ~1.9 mg 749843-87-6
8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) H 005-25 5 x 5 レmol 749843-87-6
8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) H 006-05 5 レmol ~2.3 mg 59212-44-1
8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) H 006-25 5 x 5 レmol 59212-44-1
8- Hydroxyadenine ( 8-OH-Ade ) H 007-100 100 レmol ~15 mg 21149-26-8
8- Hydroxyadenine ( 8-OH-Ade ) H 007-500 5 x 100 レmol 21149-26-8
8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) H 010-05 5 レmol ~2.4 mg 612513-15-2
8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) H 010-25 5 x 5 レmol 612513-15-2
8- Hydroxyadenosine ( 8-OH-Ado ) H 011-05 5 レmol ~1.4 mg 29851-57-8
8- Hydroxyadenosine ( 8-OH-Ado ) H 011-25 5 x 5 レmol 29851-57-8
6- Hexylthioguanosine- 3', 5'- cyclic monophosphate ( 6-HT-cGMP ) H 012 inquire pending
8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) H 013-05 5 レmol ~1.9 mg pending
8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) H 013-25 5 x 5 レmol pending
8- Hydroxyguanosine- 3', 5'- cyclic monophosphate ( 8-OH-cGMP ) H 016-01 1 レmol 21082-28-0
2- Hydroxyadenine ( 2-OH-Ade ) H 017-100 100 レmol 3373-53-3
2- Hydroxyadenine ( 2-OH-Ade ) H 017-500 5 x 100 レmol 3373-53-3
8- Hydroxyguanosine- 3', 5'- cyclic monophosphate ( 8-OH-cGMP ) H016 inquire 21082-28-0
Inosine- 3', 5'- cyclic monophosphate ( cIMP ) I 001-250 5 x 50 レmol 41092-64-2
Inosine- 3', 5'- cyclic monophosphate ( cIMP ) I 001-50 50 レmol ~18 mg 41092-64-2
5- Iodotubercidin ( 5-I-Tu ) / 7- Deaza- 7- iodoadenosine I 004-05 5 レmol ~2 mg 24386-93-4
5- Iodotubercidin ( 5-I-Tu ) / 7- Deaza- 7- iodoadenosine I 004-25 5 x 5 レmol 24386-93-4
2', 3'- Isopropylideneinosine I 005 inquire [2140-11-6]?
Inosine I 006 Inquire 58-63-9
2', 3'- Isopropylideneguanosine ( 2',3'-Ipr-Guo ) I 007 Inquire 362-76-5
Ko-Libri Library of Nucleosides and Nucleobases K 001-48 48 x 250 レl
Ko-Libri Library of Cyclic Nucleotides K 002-79 79 x 250 レl
8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) M 001-10 10 レmol ~3.8 mg 33823-18-6
8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) M 001-50 5 x 10 レmol 33823-18-6
N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) M 003-250 5 x 50 レmol 70253-67-7
N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) M 003-50 50 レmol ~21 mg 70253-67-7
2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) M 004-05 5 レmol ~2.2 mg 152218-23-0
2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) M 004-25 5 x 5 レmol 152218-23-0
2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) M 005-05 5 レmol ~2.2 mg 152218-23-0
2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) M 005-25 5 x 5 レmol 152218-23-0
2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cGMP ) M 006-10 10 レmol ~4.4 mg 58329-72-9
2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cGMP ) M 006-50 5 x 10 レmol 58329-72-9
2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cAMP ) M 007-250 5 x 50 レmol 55443-13-5
2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cAMP ) M 007-50 50 レmol ~21 mg 55443-13-5
2'- O- (N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) M 008-10 10 レmol ~4.8 mg 83707-14-6
2'- O- (N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) M 008-50 5 x 10 レmol 83707-14-6
2'- O- (N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) M 009-10 10 レmol ~5 mg 83707-15-7
2'- O- (N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) M 009-50 5 x 10 レmol 83707-15-7
N2- Methylguanosine- 3', 5'- cyclic monophosphate ( 2-Me-cGMP) M 010-05 5 レmol 205368-54-3
N2- Methylguanosine- 3', 5'- cyclic monophosphate ( 2-Me-cGMP) M 010-25 5 x 5 レmol 205368-54-3
2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) M 011-125 5 x 25 レmol 36940-87-1
2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) M 011-25 25 レmol ~11 mg 36940-87-1
N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) M 012-05 5 レmol ~2.3 mg 84433-46-5
N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) M 012-25 5 x 5 レmol 84433-46-5
2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) M 015-125 5 x 25 レmol 39118-26-8
2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) M 015-25 25 レmol ~12 mg 39118-26-8
8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) M 016-05 5 レmol ~2.9 mg 909782-76-9
8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) M 016-25 5 x 5 レmol 909782-76-9
N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) M 017-05 5 レmol ~2.9 mg 723313-27-7
N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) M 017-25 5 x 5 レmol 723313-27-7
2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) M 020-05 5 レmol ~2.4 mg 34983-48-7
2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) M 020-25 5 x 5 レmol 34983-48-7
2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) M 021-05 5 レmol ~2.8 mg 43170-89-4
2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) M 021-25 5 x 5 レmol 43170-89-4
2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) M 022-01 1 レmol ~0.6 mg 60448-20-6
2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) M 022-05 5 x 1 レmol 60448-20-6
2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) M 023-01 1 レmol ~0.6 mg 104872-93-7
2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) M 023-05 5 x 1 レmol 104872-93-7
N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ) M 024-05 5 レmol ~2.7 mg 681175-78-0
N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ) M 024-25 5 x 5 レmol 681175-78-0
N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3-MeBn)-ATP ) M 025-05 5 レmol ~3.1 mg 215321-95-2
N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3-MeBn)-ATP ) M 025-25 5 x 5 レmol 215321-95-2
N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ) M 026-05 5 レmol ~2.5 mg pending
N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ) M 026-25 5 x 5 レmol pending
N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ) M 027-05 5 レmol ~2.9 mg 252889-13-7
N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ) M 027-25 5 x 5 レmol 252889-13-7
N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ) M 028-05 5 レmol ~2.5 mg 681175-77-9
N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ) M 028-25 5 x 5 レmol 681175-77-9
N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ) M 029-05 5 レmol ~2.9 mg 252889-14-8
N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ) M 029-25 5 x 5 レmol 252889-14-8
2'- /3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) M 030-05 5 レmol ~3.2 mg 151481-86-6
2'- /3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) M 030-25 5 x 5 レmol 151481-86-6
2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) M 031-10 10 レmol ~3.9 mg 22140-20-1
2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) M 031-50 5 x 10 レmol 22140-20-1
2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) M 032-05 5 レmol ~3.3 mg 148821-03-8
2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) M 032-25 5 x 5 レmol 148821-03-8
2- Methylthioadenosine ( 2-MeS-Ado ) M 033-10 10 レmol ~3.1 mg 4105-39-9
2- Methylthioadenosine ( 2-MeS-Ado ) M 033-50 5 x 10 レmol 4105-39-9
8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) M 034-05 5 レmol ~2.5 mg 612513-16-3
8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) M 034-25 5 x 5 レmol 612513-16-3
2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) M 036-05 5 レmol ~1.9 mg [949909-73-3]
2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) M 036-25 5 x 5 レmol [949909-73-3]
2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) M 037-10 10 レmol ~4.8 mg 85287-53-2
2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) M 037-50 5 x 10 レmol 85287-53-2
N6- Methyladenosine- 5'- O- monophosphate ( 6-Me-5'-AMP ) M 038-10 10 レmol ~3.6 mg 81921-35-9
N6- Methyladenosine- 5'- O- monophosphate ( 6-Me-5'-AMP ) M 038-50 5 x 10 レmol 81921-35-9
N6- Methyladenosine- 5'- O- triphosphate ( 6-Me-ATP ) M 039-05 5 レmol 3130-39-0
N6- Methyladenosine- 5'- O- triphosphate ( 6-Me-ATP ) M 039-25 5 x 5 レmol 3130-39-0
2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) M 040-05 5 レmol ~2.8 mg 151481-85-5
2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) M 040-25 5 x 5 レmol 151481-85-5
2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) M 041-05 5 レmol ~2.9 mg 148821-02-7
2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) M 041-25 5 x 5 レmol 148821-02-7
2'-/ 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) M 042-10 10 レmol ~5 mg 85287-54-3
2'-/ 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) M 042-50 5 x 10 レmol 85287-54-3
6- Methylmercaptopurine riboside M 043 Inquire 342-69-8
6- Mercaptopurine riboside M 044 Inquire 574-25-4
2'- O- Methylguanosine M 045 Inquire 2140-71-8
8- Mercaptoguanosine M 046 Inquire 26001-38-7
2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(モ, ャ)- imidotriphosphate] ( MANT-GppNHp ) M 047-01 1 レmol ~0.7 mg 148821-01-6
2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(モ, ャ)- imidotriphosphate] ( MANT-GppNHp ) M 047-05 5 x 1 レmol 148821-01-6
2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) M 050-05 5 レmol ~1.8 mg 40269-29-2
2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) M 050-25 5 x 5 レmol 40269-29-2
2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) M 053-05 5 レmol ~2.3 mg pending
2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) M 053-25 5 x 5 レmol pending
2'- O- Methyladenosine ( 2'-O-Me-Ado ) M 054-10 10 レmol ~2.8 mg 2140-79-6
2'- O- Methyladenosine ( 2'-O-Me-Ado ) M 054-50 5 x 10 レmol 2140-79-6
8- (4- Methoxyphenylthio)adenine ( 8-pMeOPT-Ade ) M 061-10 10 レmol 696574-56-8
8- (4- Methoxyphenylthio)adenine ( 8-pMeOPT-Ade ) M 061-50 5 x 10 レmol 696574-56-8
8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) M 062-10 10 レmol ~4 mg 696574-56-8
8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) M 062-50 5 x 10 レmol 696574-56-8
8- Methylamino- cyclic inosine diphosphate ribose ( 8-MA-N1-cIDPR ) M 063-005 0.5 レmol pending
8- Methylamino- cyclic inosine diphosphate ribose ( 8-MA-N1-cIDPR ) M 063-025 5 x 0.5 レmol pending
8- Methylthio- cyclic inosine diphosphate ribose ( 8-MeS-N1-cIDPR ) M 064-005 0.5 レmol pending
8- Methylthio- cyclic inosine diphosphate ribose ( 8-MeS-N1-cIDPR ) M 064-025 5 x 0.5 レmol pending
2'- / 3'- O- (N'- Methylanthraniloyl)inosine- 5'- O- monophosphate ( MANT-5'-IMP ) M 072-10 10 レmol pending
2'- / 3'- O- (N'- Methylanthraniloyl)inosine- 5'- O- monophosphate ( MANT-5'-IMP ) M 072-50 5 x 10 レmol pending
N6- (1- Methylbutyl)adenosine- 5'- O- (3-thiotriphosphate) ( 6-(1-MeBu)-ATP-ャ-S ) M 074-05 5 レmol [pending]
N6- (1- Methylbutyl)adenosine- 5'- O- (3-thiotriphosphate) ( 6-(1-MeBu)-ATP-ャ-S ) M 074-25 5 x 5 レmol [pending]
8- (4- Mercaptobutylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-MBT-cAMP ) M 080-05 5 レmol 1033893-75-2
8- (4- Mercaptobutylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-MBT-cAMP ) M 080-25 5 x 5 レmol 1033893-75-2
N6- Methoxy- 2,6- diaminopurine- 2'- deoxyriboside- 5'- O- triphosphate ( dKTP ) M 084-05 5 レmol 189278-08-8
N6- Methoxy- 2,6- diaminopurine- 2'- deoxyriboside- 5'- O- triphosphate ( dKTP ) M 084-25 5 x 5 レmol 189278-08-8
2'- O- Methyl- cyclic diguanosine monophosphate ( 2'-O-Me-c-diGMP ) M 086-001 0.1 レmol 849214-01-3
2'- O- Methyl- cyclic diguanosine monophosphate ( 2'-O-Me-c-diGMP ) M 086-005 5 x 0.1 レmol 849214-01-3
4- Methylphenyl- 2, 4, 6- trimethylphenylsulfone ( ESI-05 ) M 092-05 5 レmol 5184-64-5
4- Methylphenyl- 2, 4, 6- trimethylphenylsulfone ( ESI-05 ) M 092-25 5 x 5 レmol 5184-64-5
8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) N 001-01 1 レmol ~0.6 mg 115993-88-9
8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) N 001-05 5 x 1 レmol 115993-88-9
8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) N 002-01 1 レmol ~0.6 mg 221905-51-7
8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) N 002-05 5 x 1 レmol 221905-51-7
8- Nitroguanine ( 8-NO2-Gua ) N 003-05 5 レmol ~1 mg 168701-80-2
8- Nitroguanine ( 8-NO2-Gua ) N 003-25 5 x 5 レmol 168701-80-2
8- Nitroguanosine ( 8-NO2-Guo ) N 004-05 5 レmol ~1.6 mg 337536-53-5
8- Nitroguanosine ( 8-NO2-Guo ) N 004-25 5 x 5 レmol 337536-53-5
モ- Nicotinamide- 8- bromohypoxanthine dinucleotide ( 8-Br-NHD+ ) N 006-05 5 レmol ~3.7 mg 477782-33-5
モ- Nicotinamide- 8- bromohypoxanthine dinucleotide ( 8-Br-NHD+ ) N 006-25 5 x 5 レmol 477782-33-5
4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) N 007-05 5 レmol ~1.9 mg 127634-21-3
4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) N 007-25 5 x 5 レmol 127634-21-3
モ- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ュ-NAD+ ) N 010-10 10 レmol ~6.9 mg 38806-38-1
モ- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ュ-NAD+ ) N 010-50 5 x 10 レmol 38806-38-1
モ- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ) N 012-001 0.1 レmol ~116 レg pending
モ- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ) N 012-005 5 x 0.1 レmol pending
モ- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ) N 013-05 5 レmol ~3.5 mg 59587-50-7
モ- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ) N 013-25 5 x 5 レmol 59587-50-7
モ- Nicotinamide- 8- bromo- 7- deazaadenine dinucleotide ( 8-Br-7-CH-NAD+ ) N 016-01 1 レmol ~0.7 mg 189876-09-3
モ- Nicotinamide- 8- bromo- 7- deazaadenine dinucleotide ( 8-Br-7-CH-NAD+ ) N 016-05 5 x 1 レmol 189876-09-3
モ- Nicotinamide- 8- bromoadenine dinucleotide ( 8-Br-NAD+ ) N 017-10 10 レmol ~7.4 mg 52977-37-4
モ- Nicotinamide- 8- bromoadenine dinucleotide ( 8-Br-NAD+ ) N 017-50 5 x 10 レmol 52977-37-4
モ- Nicotinic acid adenine dinucleotide phosphate ( モ-NAADP+ ) N 018-10 10 レmol ~7.4 mg 5502-96-5
モ- Nicotinic acid adenine dinucleotide phosphate ( モ-NAADP+ ) N 018-50 5 x 10 レmol 5502-96-5
モ- Nicotinic acid- 1, N6- ethenoadenine dinucleotide phosphate ( ュ-NAADP+ ) N 019-05 5 レmol ~3.8 mg 217313-72-9
モ- Nicotinic acid- 1, N6- ethenoadenine dinucleotide phosphate ( ュ-NAADP+ ) N 019-25 5 x 5 レmol 217313-72-9
モ- Nicotinamide- N6- (2- (6- [fluoresceinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Fluo-10-NAD+ ) N 023-001 0.1 レmol ~0.1 mg pending
モ- Nicotinamide- N6- (2- (6- [fluoresceinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Fluo-10-NAD+ ) N 023-005 5 x 0.1 レmol pending
モ- Nicotinamide- 1, N6- ethenoadenine dinucleotide phosphate ( ュ-NADP+ ) N 024-05 5 レmol ~3.8 mg 104809-28-1
モ- Nicotinamide- 1, N6- ethenoadenine dinucleotide phosphate ( ュ-NADP+ ) N 024-25 5 x 5 レmol 104809-28-1
モ- Nicotinamide- 8- methylaminoadenine dinucleotide ( 8-MA-NAD+ ) N 025-01 1 レmol 1262426-04-9
モ- Nicotinamide- 8- methylaminoadenine dinucleotide ( 8-MA-NAD+ ) N 025-05 5 x 1 レmol 1262426-04-9
モ- Nicotinamide- 8- (4- chlorophenylthio)adenine dinucleotide ( 8-pCPT-NAD+ ) N 033-01 1 レmol pending
モ- Nicotinamide- 8- (4- chlorophenylthio)adenine dinucleotide ( 8-pCPT-NAD+ ) N 033-05 5 x 1 レmol pending
モ- Nicotinamide- 8- butylthioadenine dinucleotide ( 8-BuT-NAD+ ) N 036-01 1 レmol pending
モ- Nicotinamide- 8- butylthioadenine dinucleotide ( 8-BuT-NAD+ ) N 036-05 5 x 1 レmol pending
モ- Nicotinamide- 8- cyclopentylthioadenine dinucleotide ( 8-cPeT-NAD+ ) N 037-01 1 レmol pending
モ- Nicotinamide- 8- cyclopentylthioadenine dinucleotide ( 8-cPeT-NAD+ ) N 037-05 5 x 1 レmol pending
モ- Nicotinamide- 8- ethylthioadenine dinucleotide ( 8-ET-NAD+ ) N 038-01 1 レmol pending
モ- Nicotinamide- 8- ethylthioadenine dinucleotide ( 8-ET-NAD+ ) N 038-05 5 x 1 レmol pending
モ- Nicotinamide adenine dinucleotide- 2', 3'- cyclic monophosphate ( NADcP+ / 2',3'-cyclic NADP+ ) N 050-10 10 レmol 100929-77-9
モ- Nicotinamide adenine dinucleotide- 2', 3'- cyclic monophosphate ( NADcP+ / 2',3'-cyclic NADP+ ) N 050-50 5 x 10 レmol 100929-77-9
モ- Phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) P 001-10 10 レmol ~4.7 mg 78080-27-0
モ- Phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) P 001-50 5 x 10 レmol 78080-27-0
8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) P 002-10 10 レmol ~4.3 mg 31357-06-9
8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) P 002-50 5 x 10 レmol 31357-06-9
8- Bromo- - phenyl- 1, N- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) P 003-10 10 レmol ~5.5 mg 144510-04-3
8- Bromo- - phenyl- 1, N- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) P 003-50 5 x 10 レmol 144510-04-3
8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) P 004-05 5 レmol ~2.3 mg 156816-36-3
8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) P 004-25 5 x 5 レmol 156816-36-3
8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) P 005-05 5 レmol ~2.3 mg 156816-35-2
8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) P 005-25 5 x 5 レmol 156816-35-2
N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) P 006-05 5 レmol ~2.1 mg 34051-30-4
N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) P 006-25 5 x 5 レmol 34051-30-4
8- Bromo- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) P 007-01 1 レmol ~0.6 mg 172806-20-1
8- Bromo- - phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) P 007-05 5 x 1 レmol 172806-20-1
8- Bromo- モ -phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) P 008-05 5 レmol ~2.8 mg 172806-21-2
8- Bromo- モ -phenyl- 1, N- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) P 008-25 5 x 5 レmol 172806-21-2
Purine riboside- 5'- O- triphosphate ( PuTP ) P 009-05 5 レmol ~2.5 mg 23197-96-8
Purine riboside- 5'- O- triphosphate ( PuTP ) P 009-25 5 x 5 レmol 23197-96-8
Purine riboside- 3', 5'- cyclic monophosphate ( cPuMP ) P 010-05 5 レmol ~1.7 mg 53303-84-7
Purine riboside- 3', 5'- cyclic monophosphate ( cPuMP ) P 010-25 5 x 5 レmol 53303-84-7
Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) P 011-05 5 レmol ~1.6 mg 13484-60-1
Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) P 011-25 5 x 5 レmol 13484-60-1
N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) P 012-05 5 レmol ~3.1 mg 181705-62-4
N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) P 012-25 5 x 5 レmol 181705-62-4
N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) P 013-05 5 レmol ~2.7 mg 681175-76-8
N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) P 013-25 5 x 5 レmol 681175-76-8
N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) P 014-05 5 レmol ~2.5 mg 105701-92-6
N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) P 014-25 5 x 5 レmol 105701-92-6
N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) P 015-05 5 レmol ~2.9 mg 105740-47-4
N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) P 015-25 5 x 5 レmol 105740-47-4
Purine riboside ( PuR ) / Nebularine P 016 Inquire 550-33-4
N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) P 018-05 5 レmol ~2.2 mg 169335-92-6
N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) P 018-25 5 x 5 レmol 169335-92-6
8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-575]-cAMP ) P 019-001 0.1 レmol ~72 レg pending
8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-575]-cAMP ) P 019-005 5 x 0.1 レmol pending
8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-575]-cGMP ) P 020-001 0.1 レmol ~74 レg pending
8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-575]-cGMP ) P 020-005 5 x 0.1 レmol pending
8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-575]-2'-O-Me-cAMP ) P 021-001 0.1 レmol ~74 レg pending
8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-575]-2'-O-Me-cAMP ) P 021-005 5 x 0.1 レmol pending
5'- Phosphoguanylyl- (3' -> 5')- guanosine ( pGpG ) P 023-001 0.1 レmol ~71 レg 33008-99-0
5'- Phosphoguanylyl- (3' -> 5')- guanosine ( pGpG ) P 023-005 5 x 0.1 レmol 33008-99-0
8- [ Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-450]-cAMP ) P 024-001 0.1 レmol ~72 レg pending
8- [ Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-450]-cAMP ) P 024-005 5 x 0.1 レmol pending
8- [ Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-450]-cGMP ) P 025-001 0.1 レmol ~74 レg pending
8- [ Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[ヵ-450]-cGMP ) P 025-005 5 x 0.1 レmol pending
N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-ャ-S ) P 026-05 5 レmol ~3.1 mg 944834-43-9
N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-ャ-S ) P 026-25 5 x 5 レmol 944834-43-9
N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-6-Phe-cAMPS ), sodium salt P 029-01 inquire 169335-91-5
N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-6-Phe-cAMPS ), sodium salt P 029-05 5 レmol 169335-91-5
Phosphate tris(acetoxymethyl)ester ( PO4-AM3 ) P 030-003 0.33 レmol ~0.1 mg pending
Phosphate tris(acetoxymethyl)ester ( PO4-AM3 ) P 030-015 5 x 0.33 レmol pending
8- Phenylthioadenine ( 8-PT-Ade ) P 031-10 10 レmol 908117-27-1
8- Phenylthioadenine ( 8-PT-Ade ) P 031-50 5 x 10 レmol 908117-27-1
8- Phenylthioadenosine ( 8-PT-Ado ) P 032-10 10 レmol ~3.8 mg 908117-27-1
8- Phenylthioadenosine ( 8-PT-Ado ) P 032-50 5 x 10 レmol 908117-27-1
5'- Phosphoadenylyl- (3' -> 5')- adenosine ( pApA ) P 033-001 0.1 レmol ~68 レg 3593-47-3
5'- Phosphoadenylyl- (3' -> 5')- adenosine ( pApA ) P 033-005 5 x 0.1 レmol 3593-47-3
8- Phenylethylthio- cyclic inosine diphosphate ribose ( 8-PhEtT-N1-cIDPR ) P 034-005 0.5 レmol pending
8- Phenylethylthio- cyclic inosine diphosphate ribose ( 8-PhEtT-N1-cIDPR ) P 034-025 5 x 0.5 レmol pending
1- モ- D- Ribofuranosyl- 1, 2, 4- triazole- 3- carboxamide- 5'- O- triphosphate ( Ribavirin-5'-O-triphosphate / RTP ) R 001-05 5 レmol 63142-71-2
1- モ- D- Ribofuranosyl- 1, 2, 4- triazole- 3- carboxamide- 5'- O- triphosphate ( Ribavirin-5'-O-triphosphate / RTP ) R 001-25 5 x 5 レmol 63142-71-2
Thymidine- 5'- O- (1- thiotriphosphate), Rp-isomer ( Rp-TTP-メ-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dTTP-メ-S ) T 002-05 5 レmol ~2.5 mg 83199-35-3
Thymidine- 5'- O- (1- thiotriphosphate), Rp-isomer ( Rp-TTP-メ-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dTTP-メ-S ) T 002-25 5 x 5 レmol 83199-35-3
Thymidine- 5'- O- (1- thiotriphosphate), Sp-isomer ( Sp-TTP-メ-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dTTP-メ-S ) T 003-05 5 レmol ~2.5 mg 83199-32-0
Thymidine- 5'- O- (1- thiotriphosphate), Sp-isomer ( Sp-TTP-メ-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dTTP-メ-S ) T 003-25 5 x 5 レmol 83199-32-0
Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) T 004-05 5 レmol ~1.6 mg 15548-51-3
Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) T 004-25 5 x 5 レmol 15548-51-3
Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) T 005-05 5 レmol ~1.6 mg 76567-90-3
Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) T 005-25 5 x 5 レmol 76567-90-3
2', 3', 5'- Triacetylinosine T 006 Inquire 3181-38-2
2', 3', 5'- Tri- O- benzoylguanosine ( 2',3',5'-TBnz-Guo ) T 007 Inquire 66048-53-1
Thymidine- 5'- O- (メ, モ- methylene)diphosphate ( TMP-CP ) T 008-05 5 レmol ~2 mg 55065-40-2
Thymidine- 5'- O- (メ, モ- methylene)diphosphate ( TMP-CP ) T 008-25 5 x 5 レmol 55065-40-2
N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) T 009-05 5 レmol ~1.6 mg 40027-70-1
N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) T 009-25 5 x 5 レmol 40027-70-1
5'- [(2, 2, 5, 5- Tetramethyl- 3- pyrrolin- 1- oxyl- 3- carboxylamino)adenosine ( 5'-TMPO-Ado ) T 010-05 5 レmol ~2.2 mg
5'- [(2, 2, 5, 5- Tetramethyl- 3- pyrrolin- 1- oxyl- 3- carboxylamino)adenosine ( 5'-TMPO-Ado ) T 010-25 5 x 5 レmol
Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate T 012-05 5 レmol ~2 mg [2863-04-9]??
Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate T 012-25 5 x 5 レmol [2863-04-9]??
6- Thioguanosine- 5'- O- monophosphate ( 6-T-5'-GMP ) T 014-05 5 レmol ~1.9 mg 74686-78-5
6- Thioguanosine- 5'- O- monophosphate ( 6-T-5'-GMP ) T 014-25 5 x 5 レmol 74686-78-5
6- Thioguanosine- 5'- O- diphosphate ( 6-T-GDP ) T 015-05 5 レmol ~2.3 mg 16541-19-8
6- Thioguanosine- 5'- O- diphosphate ( 6-T-GDP ) T 015-25 5 x 5 レmol 16541-19-8
6- Thioguanosine- 5'- O- triphosphate ( 6-T-GTP ) T 016-05 5 レmol ~2.7 mg 17670-19-8
6- Thioguanosine- 5'- O- triphosphate ( 6-T-GTP ) T 016-25 5 x 5 レmol 17670-19-8
2'- O- (6- [ Tetramethylrhodaminyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AHC-cGMP ) T 017-005 0.5 レmol ~461 レg pending
2'- O- (6- [ Tetramethylrhodaminyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AHC-cGMP ) T 017-025 5 x 0.5 レmol pending
2'- O- (2- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AEC-cGMP ) T 018-005 0.5 レmol ~433 レg pending
2'- O- (2- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AEC-cGMP ) T 018-025 5 x 0.5 レmol pending
2'- / 3'- O- (6- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-TAMRA-AEC-5'-GMP ) T 020-005 0.5 レmol pending
2'- / 3'- O- (6- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-TAMRA-AEC-5'-GMP ) T 020-025 5 x 0.5 レmol pending
Uridine- 3', 5'- cyclic monophosphate ( cUMP ) U 001-250 5 x 50 レmol 56632-58-7
Uridine- 3', 5'- cyclic monophosphate ( cUMP ) U 001-50 50 レmol ~16 mg 56632-58-7
Uridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-UTP-メ-S ) U 002-05 5 レmol ~2.5 mg 71214-30-7
Uridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-UTP-メ-S ) U 002-25 5 x 5 レmol 71214-30-7
Uridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-UTP-メ-S ) U 003-05 5 レmol ~2.5 mg 71214-29-4
Uridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-UTP-メ-S ) U 003-25 5 x 5 レmol 71214-29-4
Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) U 004-250 5 x 50 レmol 15718-50-0
Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) U 004-50 50 レmol ~16 mg 15718-50-0
Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) U 006-05 5 レmol ~1.7 mg 15548-52-4
Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) U 006-25 5 x 5 レmol 15548-52-4
P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate ( Ap4U / Up4A ) U 008-01 1 レmol ~0.8 mg 10527-48-7
P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate ( Ap4U / Up4A ) U 008-05 5 x 1 レmol 10527-48-7
Uridine- 5'- O- (メ, モ- methylene)diphosphate ( UMP-CP ) U 009-05 5 レmol ~2 mg 732921-73-2
Uridine- 5'- O- (メ, モ- methylene)diphosphate ( UMP-CP ) U 009-25 5 x 5 レmol 732921-73-2
Uridine- 5'- O- (3- thiotriphosphate) ( UTP-ャ-S ) U 010-05 5 レmol ~2.5 mg 79049-97-1
Uridine- 5'- O- (3- thiotriphosphate) ( UTP-ャ-S ) U 010-25 5 x 5 レmol 79049-97-1
Uridine- 5'- O- (2- thiodiphosphate) ( UDP-モ-S / UDP-beta-S ) U 011-05 5 レmol ~2.1 mg 221010-51-1
Uridine- 5'- O- (2- thiodiphosphate) ( UDP-モ-S / UDP-beta-S ) U 011-25 5 x 5 レmol 221010-51-1
Uridine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( UTP-ャ-AmNS ) U 014-05 5 レmol 72218-69-0
Uridine- 5'- O- triphosphoro- ャ- 1- (5- sulfonic acid)naphthylamidate ( UTP-ャ-AmNS ) U 014-25 5 x 5 レmol 72218-69-0
Uridine- 2'- O- monophosphate ( 2'-UMP ) U 015-05 5 レmol 131-83-9
Uridine- 2'- O- monophosphate ( 2'-UMP ) U 015-25 5 x 5 レmol 131-83-9
Uridine- 3'- O- monophosphate ( 3'-UMP ) U 016-05 5 レmol 84-53-7
Uridine- 3'- O- monophosphate ( 3'-UMP ) U 016-25 5 x 5 レmol 84-53-7
Uridine- 5'- O- diphosphate, immobilized on agarose ( UDP-Agarose ) U 017-06 0.6 ml
Uridine- 5'- O- diphosphate, immobilized on agarose ( UDP-Agarose ) U 017-25 2.5 ml
Uridine- 5'- O- diphosphate, immobilized on agarose ( UDP-Agarose ) U 017-60 6 ml
PKG inhibitor peptide W45 W 001-005 0.5 mg ~0.47 レmol pending
PKG inhibitor peptide W45 W 001-025 5 x 0.5 mg pending
Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) X 001-05 5 レmol ~1.8 mg 31319-70-7
Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) X 001-25 5 x 5 レmol 31319-70-7